<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Pathology-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">60</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 10069,
    "choices": [
      {
        "id": 40242,
        "text": "<p><span style=\"font-size:12.0pt;\">Cholesterolosis</span></p>"
      },
      {
        "id": 40243,
        "text": "<p><span style=\"font-size:12.0pt;\">Gallbladder polyp</span></p>"
      },
      {
        "id": 40244,
        "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma gallbladder</span></p>"
      },
      {
        "id": 40245,
        "text": "<p><span style=\"font-size:12.0pt;\">Strawberry gallbladder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient was diagnosed for Cholelithiasis and underwent cholecystectomy. What would be the diagnosis according to the given image below?</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/8.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p>",
    "unique_key": "Q5957385",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619238,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gallbladder polyp</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given image shows a Gall bladder specimen revealing numerous polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Gall Bladder Polyp</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Majority are either adenomyomatosis or cholesterol polyps and have no malignant potential.</span></p><p><span style=\"font-size:12.0pt;\">True adenomatous polyp occurs in 0.3\u20130.5% of the population. The risk of malignant transformation increases with increasing size of the polyp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cholesterosis&nbsp;</strong>and<strong> Option D. Strawberry Gall bladder</strong>: The interior of the gallbladder looks something&nbsp;like a strawberry. The yellow specks (submucous aggregations of cholesterol crystals and cholesterol esters) correspond to the seeds of a strawberry.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture2.jpg\" alt=\"\" width=\"300\" height=\"347\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gall bladder Carcinoma</strong>: Gall bladder Carcinoma specimen resemble chronic cholecystitis on gross examination, often with a thickened wall and possibly a mass. However, the image provided does not show the characteristics typically associated with carcinoma, such as a mass or irregular thickening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture3.jpg\" alt=\"\" width=\"300\" height=\"173\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gallbladder polyps, as seen in the image, are common and typically benign, with the risk of malignancy increasing with polyp size. Accurate identification is crucial for appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 79, 1709</strong></span></p>",
    "correct_choice_id": 40243,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 32306,
    "choices": [
      {
        "id": 129082,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maida </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>"
      },
      {
        "id": 129083,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Semolina &nbsp;</span></span></span></span></p>"
      },
      {
        "id": 129084,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oat cookies </span></span></span></span></p>"
      },
      {
        "id": 129085,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rice</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with weight loss and malabsorption on eating specific food materials. She has been diagnosed with gluten sensitive enteropathy. Which of the following can be the safest food given to her? (FMGE JULY 2023)</span></span></p>",
    "unique_key": "Q5293883",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619218,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Rice</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluten-sensitive enteropathy, also known as celiac disease, is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Gluten is a protein found in wheat, barley, rye, and oats (BROW). To manage celiac disease, patients must adhere to a strict gluten-free diet. Rice is naturally gluten-free and safe for consumption in patients with gluten-sensitive enteropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Maida</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Maida is a refined wheat flour, which contains gluten and is not safe for patients with celiac disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Semolina</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Semolina, also known as sooji, is a wheat product and contains gluten.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Oat cookies</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While oats are naturally gluten-free, they are often contaminated with gluten during processing and are not considered safe unless specifically labeled as gluten-free.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patients of gluten sensitive enteropathy should not be given the gluten rich cereals like BROW (Barley, Rye, Oat and Wheat) cereals or their derivatives like maida, sooji/semolina (as these are wheat products). So, the safest food for such patients would be rice.&nbsp; </span></span></span></span></p>",
    "correct_choice_id": 129085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 10321,
    "choices": [
      {
        "id": 41250,
        "text": "<p><span style=\"font-size:12.0pt;\">Complication of chronic GERD</span></p>"
      },
      {
        "id": 41251,
        "text": "<p><span style=\"font-size:12.0pt;\">Seen in 10% of individuals with symptomatic GERD</span></p>"
      },
      {
        "id": 41252,
        "text": "<p><span style=\"font-size:12.0pt;\">Increases risk of squamous cell carcinoma</span></p>"
      },
      {
        "id": 41253,
        "text": "<p><span style=\"font-size:12.0pt;\">Intestinal metaplasia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All are true about Barrett esophagus except: (NEET PG 2019)</span></p>",
    "unique_key": "Q6426824",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619235,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Increases risk of squamous cell carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Not squamous cell carcinoma, but esophageal adenocarcinoma is the cancer risk that is increased by Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a premalignant condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's epithelium (columnar metaplasia), dysplasia, carcinoma in situ, and esophageal adenocarcinoma develop sequentially from one another.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Microscopically, goblet cells are shown to have taken the place of the squamous esophageal epithelium (intestinal metaplasia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/8_Vq7IZ64.jpg\" alt=\"\" width=\"265\" height=\"176\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Complication of chronic GERD:</strong> True, as Barrett\u2019s esophagus commonly develops as a response to the damage from chronic acid reflux.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Seen in 10% of individuals with symptomatic GERD:</strong> True, as approximately 10% of GERD patients develop Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intestinal metaplasia:</strong> True, and is a defining characteristic of Barrett\u2019s esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett\u2019s esophagus increases the risk of esophageal adenocarcinoma due to the transformation of squamous cells to columnar cells, not squamous cell carcinoma.</span></p>",
    "correct_choice_id": 41252,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 65200,
    "choices": [
      {
        "id": 259977,
        "text": "<p><span style=\"font-size:12.0pt;\">Stop the blood transfusion and administer epinephrine</span></p>"
      },
      {
        "id": 259978,
        "text": "<p><span style=\"font-size:12.0pt;\">Continue the blood transfusion and monitor oxygen saturation</span></p>"
      },
      {
        "id": 259979,
        "text": "<p><span style=\"font-size:12.0pt;\">Administer corticosteroids and start oxygen therapy</span></p>"
      },
      {
        "id": 259980,
        "text": "<p><span style=\"font-size:12.0pt;\">Investigate for clerical errors in the blood transfusion process</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old man undergoing chemotherapy for leukemia receives a blood transfusion. Shortly after the transfusion begins, he develops sudden-onset dyspnea, wheezing, and cyanosis. What is the next appropriate step in the management of this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q8031290",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619216,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Stop the blood transfusion and administer epinephrine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The patient's sudden-onset dyspnea, wheezing, and cyanosis shortly after a blood transfusion indicate a severe allergic reaction, possibly an anaphylactic reaction. In such cases, the immediate and appropriate step is to stop the transfusion and administer epinephrine intramuscularly to counteract the life-threatening effects of the reaction. Epinephrine stabilizes mast cells, reduces airway edema, and improves circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Continuing the blood transfusion despite signs of anaphylaxis is inappropriate and dangerous, as it could worsen the reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Administering corticosteroids may help reduce inflammation in delayed reactions but is not the first-line treatment in acute anaphylaxis. Immediate epinephrine administration is critical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Investigating clerical errors is important but not the priority during an acute, life-threatening reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In cases of suspected anaphylactic reactions during blood transfusions, characterized by respiratory distress and systemic signs, the immediate management is to stop the transfusion and administer intramuscular epinephrine to stabilize the patient and prevent further complications.</span></p>",
    "correct_choice_id": 259977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 9966,
    "choices": [
      {
        "id": 39830,
        "text": "<p><span style=\"font-size:12.0pt;\">Esophagitis</span></p>"
      },
      {
        "id": 39831,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 39832,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
      },
      {
        "id": 39833,
        "text": "<p><span style=\"font-size:12.0pt;\">Barrett's esophagus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with heartburn and increased salivation. Upper gastrointestinal endoscopy was done, and the biopsy result is shown below. What is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/43.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p>",
    "unique_key": "Q3061073",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619251,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Barrett\u2019s esophagus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This image indicates the diagnostic features of Barrett's esophagus. Note the transition between esophageal squamous mucosa and Barrett metaplasia, with abundant metaplastic goblet cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-170620.png\" alt=\"\" width=\"300\" height=\"239\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a complication of chronic gastroesophageal reflux disease (GERD) characterized by intestinal metaplasia within the esophageal squamous mucosa. It is a premalignant condition that confers an increased risk of esophageal adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, patients diagnosed with Barrett's Esophagus require that periodic endoscopy with biopsy, for detection of dysplasia every 1-2 years to detect dysplasias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of dysplasia is associated with prolonged symptoms, longer segment length, increased patient age, and Caucasian</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/45.jpg\" alt=\"\" width=\"542\" height=\"475\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Esophagitis:</strong> While esophagitis, inflammation of the esophagus, may be seen in GERD, it does not show the characteristic intestinal metaplasia with goblet cells as seen in Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Squamous cell carcinoma:</strong> This type of cancer originates from the squamous cells of the esophagus and does not involve the metaplastic changes characteristic of Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Adenocarcinoma:</strong> Adenocarcinoma of the esophagus can develop from Barrett's esophagus, but the histological image provided is more consistent with the premalignant stage of Barrett's esophagus rather than adenocarcinoma itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a premalignant condition marked by intestinal metaplasia with goblet cells within the esophageal squamous mucosa, requiring regular surveillance for dysplasia and potential progression to adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1464</strong></span></p>",
    "correct_choice_id": 39833,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9959,
    "choices": [
      {
        "id": 39802,
        "text": "<p><span style=\"font-size:12.0pt;\">Membranous nephropathy</span></p>"
      },
      {
        "id": 39803,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
      },
      {
        "id": 39804,
        "text": "<p><span style=\"font-size:12.0pt;\">Membranoproliferative nephritis</span></p>"
      },
      {
        "id": 39805,
        "text": "<p><span style=\"font-size:12.0pt;\">Dense deposit disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presents with complaints of facial puffiness and frothy urine. Given below is the histological image of the condition. What do you think is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/29.jpg\" alt=\"\" width=\"300\" height=\"220\"></span></p>",
    "unique_key": "Q4631876",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619244,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Membranous nephropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image is characteristic of membranous nephropathy. The given hematoxylin and eosin (H&amp;E)-stained image shows uniform, diffuse thickening of the glomerular capillary wall. (Intense pink color)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/30.jpg\" alt=\"\" width=\"677\" height=\"265\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Membranous nephropathy is a common cause of the nephrotic syndrome in adults</strong>. It is characterized by diffuse thickening of the glomerular capillary wall due to the accumulation of electron-dense, Ig-containing deposits along the <strong>subepithelial side of the basement membrane.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a form of <strong>chronic immune-complex-mediated disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Microscopy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Light microscopy: The <strong>GBM is thickened without cellular proliferation</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Immunofluorescence microscopy: <strong>granular deposits</strong> containing lg and complement along the glomerular basement membrane</span></li><li><span style=\"font-size:12.0pt;\">Electron micrograph: electron-dense subepithelial deposits (<strong>epimembranous spikes</strong>) and effacement of foot processes of podocytes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Focal segmental glomerulosclerosis (FSGS):</strong> FSGS is characterized by segmental scarring of the glomeruli, which is not seen in the provided image. FSGS also typically presents with focal lesions rather than the diffuse thickening observed in membranous nephropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Membranoproliferative nephritis:</strong> This condition is characterized by hypercellularity and a thickened, double-contoured glomerular basement membrane, often referred to as \"tram-track\" appearance, which is different from the thickened, smooth GBM seen in membranous nephropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Dense deposit disease:</strong> Also known as Type II membranoproliferative glomerulonephritis, this condition is marked by ribbon-like electron-dense deposits within the GBM, which is not consistent with the features of membranous nephropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Membranous nephropathy is characterized by uniform, diffuse thickening of the glomerular capillary wall with subepithelial immune deposits, as evidenced by the histological image provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cortans pathologic basis of disease, page no. 1766, 1767</strong></span></p>",
    "correct_choice_id": 39802,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9816,
    "choices": [
      {
        "id": 39231,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Involves degranulation of mast cells</span></span></span></p>"
      },
      {
        "id": 39232,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgE mediated</span></span></span></p>"
      },
      {
        "id": 39233,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Can occur on first exposure</span></span></span></p>"
      },
      {
        "id": 39234,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Most commonly caused by NSAIDs</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">True about anaphylactoid reaction are all except: </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q6616586",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619240,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) IgE mediated</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactoid reactions are defined as those reactions that produce the same clinical picture with anaphylaxis but are <strong>not IgE mediated</strong>, occur through a <strong>direct nonimmune-mediated release of mediators from mast cells</strong> and/or basophils or result from direct complement activation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unlike the classic anaphylaxis which occurs on re-exposure to the allergen, the anaphylactoid reaction can occur even on the first exposure</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The most common agents that can cause an anaphylactoid reaction include NSAIDs and radiocontrast media.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to World allergy organization (WAO) anaphylaxis guidance 2020</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IgE-mediated anaphylaxis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is considered the classic and most frequent mechanism. In this type, anaphylaxis is triggered by the interaction of an allergen (usually a protein) interacting with the allergen-specific IgE/high-affinity receptor (Fc&epsilon;RI) complex expressed on effector cells, predominantly mast cells and basophils. This initiates intracellular signaling resulting in the release of preformed and de novo synthesis of mediators.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non&ndash;IgE-mediated anaphylaxis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> may be immunologic or non-immunologic</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-IgE-mediated immunologic mechanisms may involve the activation of pathways such as the complement system (anaphylatoxins, C3a, and C5a), the contact and coagulation system activation or immunoglobulin G (IgG)- mediated anaphylaxis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-immunologic mechanisms have been described for some drugs (opioids). Ethanol and physical factors, such as exercise, may be involved in triggering anaphylaxis through mechanisms which are not fully elucidated. Mast cells may be activated through receptors by certain drugs such as neuromuscular blocking agents and fluoroquinolones.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Involves degranulation of mast cells:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true for both anaphylaxis and anaphylactoid reactions, where mast cells release histamine and other mediators, leading to the symptoms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Can occur on first exposure:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true for anaphylactoid reactions, as they do not require prior exposure or sensitization to the allergen.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Most commonly caused by NSAIDs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true. NSAIDs are a common cause of anaphylactoid reactions, which can occur without prior exposure.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactoid reactions are not <strong>IgE-mediated</strong> and can occur on first exposure to the triggering substance, with NSAIDs being one of the common causes.</span></span></span></p>",
    "correct_choice_id": 39232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 9931,
    "choices": [
      {
        "id": 39690,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 39691,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 1, 4, 3</span></p>"
      },
      {
        "id": 39692,
        "text": "<p><span style=\"font-size:12.0pt;\">4, 1, 2, 3</span></p>"
      },
      {
        "id": 39693,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 1, 2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the correct sequence of cellular events of inflammation?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Rolling</span></li><li><span style=\"font-size:12.0pt;\">Cytokine mediated integrin activation</span></li><li><span style=\"font-size:12.0pt;\">Adhesion</span></li><li><span style=\"font-size:12.0pt;\">Migration</span></li></ol>",
    "unique_key": "Q5691991",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619232,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correct sequence of events during inflammation:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Rolling</span></li><li><span style=\"font-size:12.0pt;\">Cytokine mediated integrin activation</span></li><li><span style=\"font-size:12.0pt;\">Adhesion</span></li><li><span style=\"font-size:12.0pt;\">Migration</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>CELLULAR CHANGES DURING INFLAMMATION</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-153326_ZgbUP2k.jpg\" alt=\"\" width=\"1000\" height=\"637\"></u></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-103809.png\" alt=\"\" width=\"500\" height=\"247\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of intravascular cellular events during inflammation involves rolling, cytokine-mediated integrin activation, adhesion, and migration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran pathologic basis of disease 10<sup>th</sup> edition pg. 78-79</strong></span></p>",
    "correct_choice_id": 39690,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 47544,
    "choices": [
      {
        "id": 189787,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">12 and 9</span></span></span></p>"
      },
      {
        "id": 189788,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">22 and 8</span></span></span></p>"
      },
      {
        "id": 189789,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">22 and 9</span></span></span></p>"
      },
      {
        "id": 189790,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">9 and 11</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Philadelphia chromosome is caused by translocation of which of the following chromosomes? (</span></span>FMGE Jan 2024)</p>",
    "unique_key": "Q5647653",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619224,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 22 and 9</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Philadelphia chromosome, a hallmark genetic abnormality in chronic myelogenous leukemia (CML), is caused by a reciprocal translocation between the long arms of chromosomes 9 and 22, denoted as <strong>t (9;22) (q34;q11).</strong> This translocation results in the fusion of the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9, creating the <strong>BCR-ABL1 fusion gene.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The BCR-ABL1 fusion gene encodes a constitutively active tyrosine kinase, which is responsible for the uncontrolled proliferation and survival of myeloid cells in CML. The enhanced tyrosine kinase activity of the BCR-ABL1 fusion protein leads to the development of this malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The specific involvement of the long arms of chromosomes 9 and 22 in the translocation can be denoted as t(9q;22q) or t(9;22)(q34;q11), where &#39;q&#39; represents the long arm, and &#39;34&#39; and &#39;11&#39; represent the specific bands on the long arms of chromosomes 9 and 22, respectively, where the breakpoints occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Philadelphia chromosome, the hallmark genetic abnormality in chronic myelogenous leukemia (CML), is caused by a reciprocal translocation between the long arms of chromosomes 9 and 22, denoted as t(9;22)(q34;q11). This translocation creates the BCR-ABL1 fusion gene, which encodes a constitutively active tyrosine kinase responsible for the development of CML.</span></span></span></p>",
    "correct_choice_id": 189789,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 57625,
    "choices": [
      {
        "id": 229869,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATP7A gene</span></span></p>"
      },
      {
        "id": 229870,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATP7B gene</span></span></p>"
      },
      {
        "id": 229871,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 1 anti-trypsin deficiency</span></span></p>"
      },
      {
        "id": 229872,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surfactant defect</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with dyspnea, respiratory distress due to pan-acinar emphysema, and liver dysfunction is due to a likely defect in which of the following? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q7874696",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619203,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Alpha 1 anti-trypsin deficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Alpha 1 anti-trypsin deficiency is an autosomal recessive disorder</span></strong><span style=\"font-size:12.0pt\"> characterized by a deficiency of the alpha 1 anti-trypsin protein, which protects the lungs from neutrophil elastase. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This deficiency leads to the development of pan-acinar emphysema, especially in the lower lobes of <strong>the lungs, and liver dysfunction</strong>, such as cirrhosis, due to the accumulation of abnormal alpha 1 anti-trypsin in hepatocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of pulmonary and hepatic manifestations, particularly pan-acinar emphysema, is a hallmark of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. ATP7A gene:</span></strong><span style=\"font-size:12.0pt\"> Mutations in this gene are associated with Menkes disease, a disorder of copper metabolism, leading to systemic copper deficiency. It does not cause emphysema or liver dysfunction seen in alpha 1 anti-trypsin deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ATP7B gene:</span></strong><span style=\"font-size:12.0pt\"> This gene is associated with Wilson&#39;s disease, which affects copper metabolism, leading to liver disease and neurological symptoms but not emphysema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Surfactant defect:</span></strong><span style=\"font-size:12.0pt\"> Surfactant deficiency typically occurs in preterm infants, leading to respiratory distress syndrome due to immature lung development. It does not cause emphysema or liver dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha 1 anti-trypsin deficiency is associated with pan-acinar emphysema and liver dysfunction due to a deficiency of the protective alpha 1 anti-trypsin protein.</span></span></span></p>",
    "correct_choice_id": 229871,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 65198,
    "choices": [
      {
        "id": 259969,
        "text": "<p><span style=\"font-size:12.0pt;\">Post-streptococcal glomerulonephritis</span></p>"
      },
      {
        "id": 259970,
        "text": "<p><span style=\"font-size:12.0pt;\">Tubulointerstitial nephritis</span></p>"
      },
      {
        "id": 259971,
        "text": "<p><span style=\"font-size:12.0pt;\">Pyelonephritis</span></p>"
      },
      {
        "id": 259972,
        "text": "<p><span style=\"font-size:12.0pt;\">Lupus nephritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever, malaise, and flank pain after a recent course of antibiotics for a sore throat. Urinalysis reveals pyuria, hematuria, and WBC casts. There is no eosinophiluria. What is the most likely diagnosis? (Twisted PYQ)</span></p>",
    "unique_key": "Q9360753",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619214,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Pyelonephritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient\u2019s symptoms of fever, malaise, flank pain, and the presence of <strong>pyuria, hematuria, and WBC casts</strong> suggest <strong>pyelonephritis</strong>, a bacterial infection of the kidney parenchyma. The absence of eosinophiluria excludes tubulointerstitial nephritis in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Post-streptococcal glomerulonephritis:</strong> Incorrect. While hematuria and RBC casts are typical of PSGN, it occurs after streptococcal infections and does not present with WBC casts or systemic symptoms like fever and flank pain as prominently as pyelonephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tubulointerstitial nephritis:</strong> Incorrect. Tubulointerstitial nephritis is characterized by eosinophiluria, WBC casts, and a history of drug hypersensitivity. The absence of eosinophiluria makes this less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lupus nephritis:</strong> Incorrect. Lupus nephritis involves immune-mediated glomerular damage, often with RBC casts and significant proteinuria. It typically occurs in patients with systemic lupus erythematosus (SLE) and is not associated with WBC casts without other autoimmune signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pyelonephritis</strong> is a bacterial infection of the renal parenchyma and upper urinary tract. Key findings include <strong>pyuria, hematuria, and WBC casts</strong>, along with systemic symptoms like fever and flank pain. It should be distinguished from other renal conditions based on clinical and laboratory features.</span></p>",
    "correct_choice_id": 259971,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54501,
    "choices": [
      {
        "id": 217473,
        "text": "<p><span style=\"font-size:12.0pt;\">TGF-alpha</span></p>"
      },
      {
        "id": 217474,
        "text": "<p><span style=\"font-size:12.0pt;\">PDGF</span></p>"
      },
      {
        "id": 217475,
        "text": "<p><span style=\"font-size:12.0pt;\">FGF</span></p>"
      },
      {
        "id": 217476,
        "text": "<p><span style=\"font-size:12.0pt;\">TGF-beta</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a growth factor promoting proto-oncogene?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q6371080",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619243,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TGF-beta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transforming Growth Factor-beta (TGF-beta) does not promote proto-oncogenes. Instead, TGF-beta plays a crucial role in down-regulating the inflammatory response and facilitating wound healing by promoting the deposition of fibrous tissue. TGF-beta acts similarly to interleukin-10, reducing inflammation and aiding in tissue repair. Unlike other growth factors such as TGF-alpha, PDGF, and FGF, which are involved in cell proliferation and can promote proto-oncogenes, TGF-beta primarily functions to control and reduce inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TGF-alpha:</strong> Incorrect. TGF-alpha is a growth factor that promotes proto-oncogenes and is involved in cell proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PDGF</strong>: Incorrect. Platelet-Derived Growth Factor (PDGF) is a growth factor that promotes proto-oncogenes and is significant in the pathogenesis of brain tumors and other cell growth processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. FGF:</strong> Incorrect. Fibroblast Growth Factor (FGF) is another growth factor that promotes proto-oncogenes and is involved in various cellular processes, including cell growth and development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TGF-beta is not a growth factor that promotes proto-oncogenes; instead, it is involved in down-regulating the inflammatory response and facilitating wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DmWdVB5.png\" width=\"1292\" height=\"543\"></span></p>",
    "correct_choice_id": 217476,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 65201,
    "choices": [
      {
        "id": 259981,
        "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow biopsy with TRAP staining</span></p>"
      },
      {
        "id": 259982,
        "text": "<p><span style=\"font-size:12.0pt;\">Flow cytometry</span></p>"
      },
      {
        "id": 259983,
        "text": "<p><span style=\"font-size:12.0pt;\">Cytogenetics</span></p>"
      },
      {
        "id": 259984,
        "text": "<p><span style=\"font-size:12.0pt;\">Fluorescent in situ hybridization</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old male patient presents with progressive weight loss and splenomegaly. His peripheral smear shows the presence of hairy cells. Which of the following additional investigations will you do to confirm the diagnosis? (Twisted PYQ)</span></p>",
    "unique_key": "Q3694500",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619217,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Bone marrow biopsy with TRAP staining</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of progressive weight loss, splenomegaly, and peripheral smear findings of hairy cells is suggestive of Hairy Cell Leukemia (HCL). The definitive diagnostic test is a bone marrow biopsy, coupled with Tartrate-Resistant Acid Phosphatase (TRAP) staining, which shows positivity in hairy cells and is a classic hallmark of this disease. TRAP positivity confirms the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Flow cytometry is useful in confirming the immunophenotype of hairy cells (CD11c+, CD25+, CD103+), but it is not the definitive diagnostic test when TRAP staining can provide a direct confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Cytogenetics can provide additional insights into chromosomal abnormalities but is not required for primary diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Fluorescent in situ hybridization (FISH) may identify genetic alterations but is not the primary diagnostic tool for HCL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">For a patient suspected of having Hairy Cell Leukemia, a bone marrow biopsy with TRAP staining is the gold standard for diagnosis, as it directly identifies the characteristic features of hairy cells.</span></p>",
    "correct_choice_id": 259981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10462,
    "choices": [
      {
        "id": 41814,
        "text": "<p><span style=\"font-size:12.0pt;\">Moderate or regular exercise for 30 min</span></p>"
      },
      {
        "id": 41815,
        "text": "<p><span style=\"font-size:12.0pt;\">Decrease stress</span></p>"
      },
      {
        "id": 41816,
        "text": "<p><span style=\"font-size:12.0pt;\">Decreasing calorie intake by 30 percent</span></p>"
      },
      {
        "id": 41817,
        "text": "<p><span style=\"font-size:12.0pt;\">Pharmacological intervention with proton pump inhibitors</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following measures are associated with an increased life span? (NEET PG 2022)</span></p>",
    "unique_key": "Q6858435",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619242,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreasing calorie intake by 30 percent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreasing calorie intake by 30 percent will increase lifespan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Caloric restriction reduces the severity of oxidative damage as well as the resulting decline in function. It lowers the steady-state concentrations of oxidative damage products in proteins, DNA, and lipids. This is due to a decrease in mitochondrial superoxide anion and hydrogen peroxide production and an increase in antioxidant production. Caloric restriction slows the rate of energy metabolism overall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Caloric restriction postpones the onset of age-related diseases like cancer (including lymphomas, breast and prostate cancers), nephropathy, and cataracts. Caloric restriction also reduces the onset of diabetes, hypertension, hyperlipidemia, and the development of autoimmune diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Moderate or regular exercise for 30 min</strong>: While exercise has numerous health benefits and can improve quality of life and reduce the risk of chronic diseases, it has not been directly linked to the same extent of lifespan extension as caloric restriction in scientific studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Decrease stress</strong>: Reducing stress can improve health outcomes and prevent stress-related diseases, but specific lifespan extension evidence is less robust compared to caloric restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pharmacological intervention with proton pump inhibitors</strong>: Proton pump inhibitors are used to treat gastrointestinal conditions like acid reflux and ulcers. They are not associated with increased lifespan and may have adverse effects if used long-term.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Caloric restriction, by decreasing calorie intake by 30 percent, is associated with an increased lifespan and the postponement of age-related diseases. It reduces oxidative damage, slows metabolism, and mitigates the onset of various chronic conditions.</span></p>",
    "correct_choice_id": 41816,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10491,
    "choices": [
      {
        "id": 41930,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histiocytes</span></span></span></p>"
      },
      {
        "id": 41931,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Birbeck granules</span></span></span></p>"
      },
      {
        "id": 41932,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eosinophils</span></span></span></p>"
      },
      {
        "id": 41933,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cells</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with lytic lesions on the skull is suspected of a diagnosis of Langerhans cell histiocytosis. Which of the following is a characteristic finding on electron microscopy? (AIIMS NOV 2021)</span></span></p>",
    "unique_key": "Q8947756",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619215,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Birbeck granules</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of Birbeck granules in the cytoplasm is a characteristic finding of Langerhans cell histiocytosis (LCH) on electron microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Birbeck granules have a dilated terminal end producing a tennis racket-like appearance. It contains the protein langerin (<strong>CD207).</strong> It is seen on electron microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-395.jpg\" style=\"height:335px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Histiocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While LCH involves histiocytic cells (specifically Langerhans cells), the mere presence of histiocytes is not specific to LCH. Many other conditions can also involve histiocytes, so this option is too general.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Eosinophils</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Eosinophils are often present in LCH lesions, contributing to the inflammatory response, but they are not a characteristic finding on electron microscopy and are not specific to LCH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Giant cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Giant cells may be seen in various granulomatous conditions but are not a characteristic finding specific to LCH on electron microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of <strong>Birbeck granules</strong> on electron microscopy is a <strong>characteristic finding</strong> in <strong>Langerhans cell histiocytosis (LCH)</strong>, confirming the diagnosis of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition Pg 1168</span></strong></span></span></p>",
    "correct_choice_id": 41931,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 43955,
    "choices": [
      {
        "id": 175483,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 175484,
        "text": "<p><span style=\"font-size:12.0pt;\">Aplastic Anaemia</span></p>"
      },
      {
        "id": 175485,
        "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anaemia</span></p>"
      },
      {
        "id": 175486,
        "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old vegetarian patient presented with weakness and reduced work capacity. He had a Hb of 10gm/dl and MCV-110. What is the most likely diagnosis?&nbsp;(INICET NOV 2023)</span></p>",
    "unique_key": "Q6778398",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619227,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Megaloblastic anemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Megaloblastic anemia&nbsp;</strong>is characterized by the presence of large, abnormal red blood cells (megaloblasts) in the bone marrow. It is often caused by deficiencies in vitamin B12 or folic acid, both crucial for DNA synthesis in the production of red blood cells. The high mean corpuscular volume (MCV-110) indicates that the red blood cells are larger than normal, which is typical in megaloblastic anemia. Being vegetarian, the patient is at a higher risk of vitamin B12 deficiency, commonly seen in diets lacking in animal products.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iron deficiency anemia</strong>: Typically presents with a low MCV (microcytic anemia), not high, as it indicates smaller than normal red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aplastic anemia</strong>: Involves pancytopenia (reduction of all blood cell types) and does not typically present with high MCV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thalassemia</strong>: Generally presents with a low MCV and affects the production of hemoglobin. It is a genetic disorder rather than related to dietary habits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of anemia with high MCV, especially in vegetarians or those with dietary restrictions, megaloblastic anemia should be considered. Vitamin B12 and folate levels should be assessed to confirm the diagnosis, and dietary intake of these vitamins should be evaluated and corrected if deficient.</span></p>",
    "correct_choice_id": 175485,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 10107,
    "choices": [
      {
        "id": 40394,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 2</span></span></span></p>"
      },
      {
        "id": 40395,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 1</span></span></span></p>"
      },
      {
        "id": 40396,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 4</span></span></span></p>"
      },
      {
        "id": 40397,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 3</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoscopic and barium swallow images of a lesion in the esophagus of a patient are as shown below. What is the expected histopathological finding?</span></span> (AIIMS MAY 2017)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/36.jpg\" style=\"height:251px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/37.jpg\" style=\"height:417px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/38.jpg\" style=\"height:281px; width:400px\" /></span></span></span></p>",
    "unique_key": "Q5610336",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619256,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Image 3 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shows an esophageal exophytic growth on endoscopy. <strong>Barium swallow reveals an</strong> <strong>apple core appearance in the middle 1/3 of the esophagus suggestive of squamous cell carcinoma</strong>. The characteristic histopathological finding in this condition are nests of stratified malignant cells and keratin pearls, which are noted in image 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In contrast to adenocarcinoma, half of squamous cell carcinomas occur in the middle third of the esophagus. Squamous cell carcinoma begins as an in-situ lesion termed squamous dysplasia (this lesion is referred to as intraepithelial neoplasia or carcinoma in situ at other sites). Early lesions appear as small, gray-white, plaque-like thickenings. Over months to years, they grow into tumor masses that may be polypoid or exophytic and protrude into and obstruct the lumen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-110450.png\" style=\"height:249px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma of the esophagus typically occurs in the middle third of the esophagus and is characterized histologically by nests of stratified malignant cells and keratin pearls, as seen in Image 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease 8th edition Pg 1472, 1473</span></strong></span></span></p>",
    "correct_choice_id": 40397,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 10013,
    "choices": [
      {
        "id": 40018,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
      },
      {
        "id": 40019,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma lung</span></span></span></p>"
      },
      {
        "id": 40020,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small cell cancer lung</span></span></span></p>"
      },
      {
        "id": 40021,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large cell carcinoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient presented in OPD with hemoptysis. On examination, a hilar mass was noticed. The histopathological image is shown below. Immunohistochemistry revealed that the cells were positive for p40. What is the likely diagnosis?&nbsp;(INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/11_kocFFZn.jpg\" style=\"height:200px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q5302655",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619206,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Squamous cell carcinoma</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical history and the histopathological findings showing keratin pearls are suggestive of squamous cell carcinoma of the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor arises in a large bronchus and are prone to massive necrosis and cavitation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The tumor is diagnosed microscopically by identification of either intercellular bridges or keratinization or keratin/squamous pearls.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is positive for p40 and p63 markers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-120453.jpg\" style=\"height:505px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Adenocarcinoma lung</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Generally occurs in the peripheral regions of the lung and is often associated with mutations like KRAS, EGFR, or ALK. Immunohistochemical markers like TTF-1 and Napsin-A would be positive, not p40.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Small cell cancer lung</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type is strongly associated with smoking and typically occurs centrally. However, it is identified by markers such as chromogranin, synaptophysin, and CD56, not p40.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Large cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a diagnosis of exclusion, where the tumor lacks the histological characteristics of other types of lung cancers. It is not associated with p40 positivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311_T9eOCZG.jpg\" style=\"height:917px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113157_GHno4ZQ.jpg\" style=\"height:747px; width:1000px\" /></p>",
    "correct_choice_id": 40018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10282,
    "choices": [
      {
        "id": 41094,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilia A</span></span></span></p>"
      },
      {
        "id": 41095,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilia B</span></span></span></p>"
      },
      {
        "id": 41096,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Von Willebrand disease</span></span></span></p>"
      },
      {
        "id": 41097,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilia C</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prolonged bleeding time is seen in? (NEET PG 2018)</span></span></span></p>",
    "unique_key": "Q3012901",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619210,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Von Willebrand disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Von Willebrand disease (VWD) is characterized by prolonged bleeding time due to a qualitative or quantitative deficiency of von Willebrand factor (VWF), a critical protein in platelet adhesion and aggregation processes. Prolonged APTT (Activated Partial Thromboplastin Time) is also seen in this condition because VWF stabilizes factor VIII, an essential clotting factor. The deficiency or dysfunction of VWF thus impacts both primary hemostasis (bleeding time) and secondary hemostasis (APTT).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A. Hemophilia A and B. Hemophilia B</span></strong><span style=\"font-size:12.0pt\">: These conditions involve deficiencies in clotting factors VIII and IX, respectively, which primarily affect the intrinsic coagulation pathway but not typically the bleeding time.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hemophilia C</span></strong><span style=\"font-size:12.0pt\">: Known as a deficiency in factor XI, this condition also typically affects the intrinsic pathway and APTT but not bleeding time.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prolonged bleeding time and prolonged APTT is seen in Von Willebrand disease.</span></span></span></p>",
    "correct_choice_id": 41096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9805,
    "choices": [
      {
        "id": 39187,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inflammasome</span></span></span></p>"
      },
      {
        "id": 39188,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Toll-like receptors (TLRs)</span></span></span></p>"
      },
      {
        "id": 39189,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P selectin</span></span></span></p>"
      },
      {
        "id": 39190,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Manoreceptor</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is involved in recognition and clearance of necrotic cells?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q5447037",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619234,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;<strong>A) Inflammasome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inflammasomes are involved in the recognition and clearance of necrotic cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inflammasomes are large cytosolic multiprotein complexes that assemble in response to detection of infection- or stress-associated stimuli and <strong>lead to the activation of caspase-1-mediated inflammatory responses</strong>, including cleavage and unconventional secretion of the leaderless proinflammatory <strong>cytokines IL-1&beta; and IL-18,</strong> and initiation of an inflammatory form of cell death referred to as <strong>pyroptosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inflammasomes are involved in pyroptosis, a process of programmed cell death distinct from apoptosis and necrosis. This process is <strong>dependent on caspases 1, 4, and 5 and is responsible for killing of infected cells</strong>. It occurs in the following sequence:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activation of inflammasome complex by infected cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This causes activation of caspase-1</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This results in generation of IL-1, which is responsible for fever, inflammation, leukocyte recruitment.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/948.jpg\" style=\"height:283px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Toll-like receptors (TLRs):</span></strong><span style=\"font-size:12.0pt\"> Toll-like receptors are pattern recognition receptors that detect pathogen-associated molecular patterns (PAMPs) and play a significant role in initiating the innate immune response. However, they are not directly involved in the recognition or clearance of necrotic cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. P selectin:</span></strong><span style=\"font-size:12.0pt\"> P selectin is a cell adhesion molecule found on the surface of activated endothelial cells and platelets. It mediates the initial interactions between leukocytes and endothelial cells during inflammation, but it is not involved in the recognition or clearance of necrotic cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Manoreceptor:</span></strong><span style=\"font-size:12.0pt\"> This appears to be a typographical error, possibly meant to refer to the mannose receptor. The mannose receptor is involved in recognizing microbial sugars and is part of the immune system&#39;s response to pathogens. However, it is not involved in the clearance of necrotic cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inflammasomes are crucial in the recognition and clearance of necrotic cells by activating caspase-1 and inducing the secretion of pro-inflammatory cytokines, as well as triggering pyroptosis, an inflammatory form of cell death.</span></span></span></p>",
    "correct_choice_id": 39187,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 43953,
    "choices": [
      {
        "id": 175475,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Fluoroscein isothiocyanate</span></span></span></p>"
      },
      {
        "id": 175476,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Alkaline phosphatase</span></span></span></p>"
      },
      {
        "id": 175477,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Diamino benzidene</span></span></span></p>"
      },
      {
        "id": 175478,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Benzene</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following stains cause brown color to Her 2 neu cells of breast carcinoma as shown in the image?&nbsp;(INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-172631.JPG\" style=\"height:223px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q3263246",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619219,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Ans. C) Diamino benzidene</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diaminobenzidine (DAB) is commonly used as a chromogen in immunohistochemistry. It reacts with the peroxidase enzyme in a substrate solution, producing a brown precipitate that is visible under a microscope, marking the antigen-antibody binding site.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Fluorescein Isothiocyanate:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a fluorochrome and not used for color development in traditional histopathological stains, but rather for fluorescence microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Alkaline Phosphatase:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This enzyme can be used in immunohistochemistry, typically resulting in red or blue stains, depending on the substrate used, not brown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Benzene:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is an organic solvent and not used as a chromogen in histopathology or immunohistochemistry.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For staining specific proteins like Her2 in breast carcinoma tissues, diaminobenzidine (DAB) is a preferred chromogen for peroxidase-mediated reactions in immunohistochemistry, yielding a distinct brown coloration which highlights the presence of the target antigen.</span></span></span></p>",
    "correct_choice_id": 175477,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 24745,
    "choices": [
      {
        "id": 98941,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-U3 RNP</span></span></span></p>"
      },
      {
        "id": 98942,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-centromere antibody</span></span></span></p>"
      },
      {
        "id": 98943,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-PM-Scl antibody</span></span></span></p>"
      },
      {
        "id": 98944,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Jo-1 antibody</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman, 35 years old, arrives with symptoms of skin thickening, weakened muscles, and paleness in the extremities when exposed to cold temperatures. Her ANA and anti-Scl-70 antibody tests yield positive results. Elevated levels of creatinine kinase are observed, and a muscle biopsy reveals perifascicular infiltration. Which antibody is linked to these findings?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q9147109",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619209,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Anti-PM-Scl antibody </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given patient presenting symptoms that indicate diffuse systemic sclerosis and dermatomyositis/polymyositis, is highly probable to have an overlap syndrome [Combinations of three connective tissue diseases, i.e., systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and&nbsp;polymyositis&nbsp;(PM) or&nbsp;dermatomyositis&nbsp;(DM)].</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-PM-Scl antibodies are characteristically found in patients with overlap syndromes, which involve features of systemic sclerosis combined with polymyositis or dermatomyositis. These overlap syndromes involve a combination of autoimmune conditions, often including systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis (PM) or dermatomyositis (DM).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Anti-U3 RNP</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-U3 RNP antibodies are typically associated with systemic sclerosis but can be found in both limited and diffuse forms of the disease. They are not specifically linked to the overlap syndrome seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Anti-centromere antibody</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-centromere antibodies are most commonly associated with limited systemic sclerosis (CREST syndrome), not the diffuse form or the overlap syndrome involving myositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Anti-Jo-1 antibody</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-Jo-1 antibodies are strongly associated with polymyositis and dermatomyositis, particularly with lung involvement, but they are less common than Anti-PM-Scl antibodies in patients with overlap syndromes involving systemic sclerosis and myositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-PM-Scl antibodies are commonly associated with overlap syndromes involving systemic sclerosis and myositis, making them the likely antibody in patients presenting with features of both conditions.</span></span></span></p>",
    "correct_choice_id": 98943,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 10322,
    "choices": [
      {
        "id": 41254,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parkinson Disease</span></span></span></p>"
      },
      {
        "id": 41255,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alzheimer&#39;s disease</span></span></span></p>"
      },
      {
        "id": 41256,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Schizophrenia</span></span></span></p>"
      },
      {
        "id": 41257,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Huntington&#39;s Disease</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diseases is most commonly associated with Down&#39;s syndrome: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q5990673",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619236,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Alzheimer&rsquo;s disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Individuals with Down&rsquo;s syndrome are at a significantly higher risk of developing Alzheimer&rsquo;s disease, often in their 30s and 40s, due to the presence of three copies of chromosome 21, which contains the APP gene involved in the production of amyloid precursor protein&mdash;a key factor in Alzheimer&rsquo;s pathology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Parkinson Disease:</span></strong><span style=\"font-size:12.0pt\"> Not specifically associated with Down&#39;s syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Schizophrenia:</span></strong><span style=\"font-size:12.0pt\"> No significant correlation between Down&#39;s syndrome and schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Huntington&#39;s Disease:</span></strong><span style=\"font-size:12.0pt\"> No direct association with Down&#39;s syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Conditions most commonly associated with Down&#39;s syndrome:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congenital heart disease (in about 35% of cases)</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gastrointestinal anomalies (in about 10%)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic serous otitis media (in &gt;50%)</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypothyroidism</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alzheimer&#39;s disease (in the 30&#39;s and 40&#39;s)</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epilepsy (in about 10%)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ocular disorders</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced fertility</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced life span (Often due to complications like infections)</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 41255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10105,
    "choices": [
      {
        "id": 40386,
        "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
      },
      {
        "id": 40387,
        "text": "<p><span style=\"font-size:12.0pt;\">Schwannoma</span></p>"
      },
      {
        "id": 40388,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      },
      {
        "id": 40389,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old patient presents with bilateral proptosis. The biopsy from the region shows this pattern. What is the likely diagnosis?</span> (AIIMS MAY 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/33.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p>",
    "unique_key": "Q2685159",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619255,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Schwannoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical history and biopsy picture is characteristic of schwannoma showing hypercellular areas (Antoni A), including Verocay bodies, as well as looser (hypocellular) areas, myxoid regions (Antoni B).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/34.jpg\" alt=\"\" width=\"400\" height=\"257\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/35.jpg\" alt=\"\" width=\"400\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schwannomas are well-circumscribed, encapsulated masses that are attached to the nerve but can be separated from it. Tumors form firm, gray masses that may have areas of cystic and xanthomatous change.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On microscopic examination tumors show a mixture of two growth patterns:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni A pattern of growth</strong>, elongated cells with cytoplasmic processes are arranged in fascicles in areas of moderate to high cellularity and scant stromal matrix; the <strong>\u201cnuclear-free zones\u201d of processes that lie between the regions of nuclear palisading are termed Verocay bodies.</strong></span></li><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni B pattern of growth</strong>, the tumor is less densely cellular (hypocellular) and consists of a loose meshwork of cells, <strong>microcysts</strong> and myxoid stroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Leiomyoma</strong>: Leiomyomas are benign smooth muscle tumors that do not typically present with the histological features observed in the provided image, such as Verocay bodies or the Antoni A/B patterns seen in schwannomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rhabdomyosarcoma</strong>: Rhabdomyosarcoma is a malignant tumor of skeletal muscle origin, often characterized by spindle-shaped cells and cross-striations on histology. It lacks the distinctive Antoni A and B patterns seen in schwannomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fibromatosis</strong>: Fibromatosis refers to a group of benign fibrous tissue proliferations that are locally aggressive but lack the encapsulated, well-circumscribed nature of schwannomas. The histology of fibromatosis does not show the Antoni A and B patterns or Verocay bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schwannomas are benign nerve sheath tumors with distinct Antoni A and B growth patterns, including Verocay bodies. These features, along with the clinical presentation, are key to the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical presentations:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ufuhqjF.png\" width=\"1178\" height=\"951\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page no - 2595</strong></span></p>",
    "correct_choice_id": 40387,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 57624,
    "choices": [
      {
        "id": 229865,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Silicosis</span></span></p>"
      },
      {
        "id": 229866,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anthracosis</span></span></p>"
      },
      {
        "id": 229867,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berylliosis</span></span></p>"
      },
      {
        "id": 229868,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asbestosis</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A worker in an industry for the last 20 years develops dry cough and chest tightness. He had the following finding in his pulmonary biopsy. What is the likely diagnosis? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf3.jpg\" style=\"height:712px; width:237px\" /></span></span></span></p>",
    "unique_key": "Q7724440",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619202,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Asbestosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The biopsy image and clinical history suggest a diagnosis of asbestosis. Asbestosis is a lung disease caused by prolonged inhalation of asbestos fibers, commonly seen in workers exposed to construction, shipyard, or insulation industries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic finding in the biopsy is the presence of asbestos bodies, which appear as beaded or dumbbell-shaped fibers coated with iron-rich proteinaceous material, giving a beaded appearance. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-131635.jpg\" style=\"height:383px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is the key diagnostic feature that differentiates asbestosis from other pneumoconioses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Silicosis:</span></strong><span style=\"font-size:12.0pt\"> Typically occurs in workers exposed to silica dust, such as those in mining, sandblasting, or construction. It is characterized by nodular fibrosis in the upper lobes and does not show the beaded appearance of asbestos fibers on biopsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anthracosis:</span></strong><span style=\"font-size:12.0pt\"> Also known as coal worker&rsquo;s pneumoconiosis, this condition results from the inhalation of coal dust. It presents with black lung tissue and anthracotic pigment but lacks the distinct asbestos bodies seen in asbestosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Berylliosis:</span></strong><span style=\"font-size:12.0pt\"> Caused by inhalation of beryllium particles, typically affecting workers in the aerospace, electronics, or manufacturing industries. It presents with non-caseating granulomas on biopsy, not the beaded asbestos fibers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asbestosis is characterized by the presence of asbestos bodies with a beaded or dumbbell appearance on lung biopsy, often seen in workers with long-term exposure to asbestos fibers.</span></span></span></p>",
    "correct_choice_id": 229868,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9838,
    "choices": [
      {
        "id": 39319,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      },
      {
        "id": 39320,
        "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
      },
      {
        "id": 39321,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
      },
      {
        "id": 39322,
        "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient working in a factory presented with lung fibrosis and thickening of pleura.&nbsp;Biopsy was done. Diagnosis from the histopathology picture is?</span> (AIIMS MAY 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/965.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
    "unique_key": "Q4008117",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619250,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asbestosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This clinical scenario and image showing typical asbestos bodies are suggestive of asbestosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Asbestosis is a type of pneumoconiosis associated with asbestos exposure. The disease-causing capabilities of the different forms of asbestos depend on concentration, size, shape, and solubility. This condition is <strong>marked by diffuse pulmonary interstitial fibrosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Grossly</strong>, the affected lungs are small and firm with <strong>cartilage-like thickening of the pleura</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123503.png\" alt=\"\" width=\"600\" height=\"220\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sectioned surface shows variable degree of pulmonary fibrosis, especially in the<strong> </strong>advanced cases may show cystic changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histologically, the following changes are observed:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Non-specific interstitial fibrosis.</span></li><li><span style=\"font-size:12.0pt;\">Presence of characteristic <strong>asbestos bodies</strong> - asbestos fibres coated with glycoprotein and hemosiderin and appear beaded or dumbbell-shaped. The coating <strong>stains positively for Prussian blue reaction.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note: Asbestos exposure is associated with malignant mesothelioma, </strong>a rare and aggressive cancer of the pleura.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123702.png\" alt=\"\" width=\"1000\" height=\"213\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-115000.png\" alt=\"\" width=\"400\" height=\"192\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Microscopic appearance</strong> of asbestos body. An asbestos body is an asbestos fibre coated with glycoprotein and hemosiderin giving it beaded or dumbbell \u2013 shaped appearance with bulbous ends.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Silicosis</strong>: Another type of pneumoconiosis caused by inhalation of silica dust, but it does not produce asbestos bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberculosis</strong>: An infectious disease primarily caused by Mycobacterium tuberculosis, characterized by granulomas and caseating necrosis, not by the presence of asbestos bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mesothelioma</strong>: While asbestos exposure is a risk factor for mesothelioma, the histological appearance in this case is more indicative of asbestosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Asbestosis&nbsp;</strong>is identified by the presence of characteristic <strong>asbestos bodies</strong> within the lung tissue, which are asbestos fibers coated with glycoproteins and hemosiderin, and it is commonly associated with <strong>asbestos exposure</strong> in occupational settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 1309</strong></span></p>",
    "correct_choice_id": 39319,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 65202,
    "choices": [
      {
        "id": 259985,
        "text": "<p><span style=\"font-size:12.0pt;\">Angelman syndrome</span></p>"
      },
      {
        "id": 259986,
        "text": "<p><span style=\"font-size:12.0pt;\">Prader-Willi syndrome</span></p>"
      },
      {
        "id": 259987,
        "text": "<p><span style=\"font-size:12.0pt;\">Beckwith-Wiedemann syndrome</span></p>"
      },
      {
        "id": 259988,
        "text": "<p><span style=\"font-size:12.0pt;\">Edward syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the likely diagnosis in a patient with the image of chromosome 15 represented here? (Twisted PYQ)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20162217.png\" width=\"262\" height=\"552\"></span></p>",
    "unique_key": "Q2188662",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619221,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A) Angelman syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p><br><span style=\"font-size:12.0pt;\">The image represents chromosome 15, showing a deletion specifically on the maternal chromosome. Angelman syndrome is caused by the deletion or inactivation of the maternal copy of chromosome 15q11-q13.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This genetic disorder is characterized by severe intellectual disability, speech impairment, ataxia, seizures, and a characteristic happy demeanor with frequent smiling and laughter. The primary causes of Angelman syndrome are maternal deletion and paternal uniparental disomy (paternal UPD), where two paternal chromosome copies are active, and the maternal copy is absent or silenced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prader-Willi syndrome</strong>: Prader-Willi syndrome results from a deletion of the paternal chromosome 15q11-q13 or maternal UPD. It presents with hypotonia, hyperphagia leading to obesity, and intellectual disability, which is different from Angelman syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Beckwith-Wiedemann syndrome</strong>: Beckwith-Wiedemann syndrome is caused by epigenetic or genetic alterations involving chromosome 11p15, not chromosome 15. It is characterized by macrosomia, organomegaly, and an increased risk of embryonal tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Edward syndrom</strong>e: Edward syndrome (Trisomy 18) is caused by an extra chromosome 18 and does not involve deletions on chromosome 15. It presents with intellectual disability, heart defects, and distinct physical anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Angelman syndrome is caused by a deletion or inactivation of the maternal chromosome 15q11-q13 or by paternal uniparental disomy. It is characterized by severe intellectual disability, a cheerful demeanor, and motor and speech impairments.</span></p>",
    "correct_choice_id": 259985,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 9804,
    "choices": [
      {
        "id": 39183,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Natural killer (NK) cells only</span></span></span></p>"
      },
      {
        "id": 39184,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Macrophages only</span></span></span></p>"
      },
      {
        "id": 39185,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NK cells, neutrophils and eosinophils</span></span></span></p>"
      },
      {
        "id": 39186,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neutrophils and eosinophils only</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody-dependent cellular cytotoxicity (ADCC) is seen with:</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q2614850",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619233,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) NK cells, neutrophils and eosinophils</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibody-dependent cellular cytotoxicity (ADCC) is mediated by NK cells, neutrophils and eosinophils (killing certain parasitic worms like helminths via lgE antibodies).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In ADCC, cells/ antigens are coated with IgG antibodies. These are killed by effector cells like NK cells and macrophages. These effector cells bind to the target by their receptors for the Fc fragment of IgG and <strong>cell lysis proceeds without phagocytosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/947.jpg\" style=\"height:220px; width:700px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of NK Cells:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NK cells are key mediators of ADCC. They express the Fc receptor CD16 (Fc&gamma;RIII), which specifically recognizes the Fc portion of IgG antibodies bound to target cells. Upon engagement, NK cells degranulate, releasing cytotoxic molecules that induce apoptosis in the target cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Neutrophils and Eosinophils:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosinophils are particularly involved in the ADCC response against larger parasites, such as helminths, where they utilize IgE antibodies to recognize and attack these pathogens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibody-dependent cellular cytotoxicity (ADCC) is primarily mediated by NK cells, neutrophils, and eosinophils, which kill target cells coated with antibodies through mechanisms that do not involve phagocytosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Pg no. 356</span></strong></span></span></p>",
    "correct_choice_id": 39185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 47930,
    "choices": [
      {
        "id": 191315,
        "text": "<p><span style=\"font-size:12.0pt;\">Inherited trait with hyposegmented neutrophils</span></p>"
      },
      {
        "id": 191316,
        "text": "<p><span style=\"font-size:12.0pt;\">Acquired anomaly may be seen in myelodysplasia</span></p>"
      },
      {
        "id": 191317,
        "text": "<p><span style=\"font-size:12.0pt;\">Associated with normal survival of neutrophils</span></p>"
      },
      {
        "id": 191318,
        "text": "<p><span style=\"font-size:12.0pt;\">Associated with large platelets</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Pelger-Huet Anomaly is false? (NEET PG 2015)</span></p>",
    "unique_key": "Q3168203",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619226,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: D. Associated with large platelets.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelger-Huet anomaly is an autosomal dominant disorder characterized by hypo segmented neutrophils with coarse, clumped chromatin, typically appearing as bilobed (\"pince-nez\" or \"spectacle-shaped\") nuclei. It is not associated with large platelets. The anomaly affects granulocyte nuclear segmentation but does not impact platelet morphology. Large platelets are more commonly associated with other conditions such as immune thrombocytopenia, Bernard-Soulier syndrome, or May-Hegglin anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Inherited trait with hypo segmented neutrophils</strong> - This is a true statement. The hereditary form of Pelger-Huet anomaly is an autosomal dominant condition characterized by hypo segmented neutrophils with coarse clumped chromatin and normal neutrophil function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acquired anomaly may be seen in myelodysplasia</strong> - This is a true statement. Pseudo-Pelger-Huet cells are commonly seen in myelodysplastic syndromes. These cells are one of the characteristic findings of dysgranulopoiesis in MDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Associated with normal survival of neutrophils</strong> - This is a true statement. Despite the nuclear abnormality, neutrophil function and survival remain normal in hereditary Pelger-Huet anomaly. The condition is generally benign and does not affect the functional capabilities of neutrophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelger-Huet anomaly affects nuclear segmentation of neutrophils but does not impact platelet morphology; the abnormal hypo segmented neutrophils retain normal function and survival time in the hereditary form of the condition.</span></p>",
    "correct_choice_id": 191318,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10371,
    "choices": [
      {
        "id": 41450,
        "text": "<p><span style=\"font-size:12.0pt;\">Infective endocarditis</span></p>"
      },
      {
        "id": 41451,
        "text": "<p><span style=\"font-size:12.0pt;\">Rheumatic heart disease</span></p>"
      },
      {
        "id": 41452,
        "text": "<p><span style=\"font-size:12.0pt;\">Libman-Sacks endocarditis</span></p>"
      },
      {
        "id": 41453,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-bacterial thrombotic carditis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Large, friable, irregular vegetations on heart valves are seen in which condition? (NEET PG 2020)</span></p>",
    "unique_key": "Q8226166",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619198,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Infective endocarditis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Large, friable, irregular vegetations on heart valves are seen in infective endocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The aortic and mitral valves are the most commonly affected</strong>, but the right heart valves may also be involved in some cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vegetations can be single or multiple, with one or more valves involved<strong>. Embolization</strong> is common and, due to the presence of virulent organisms in the emboli, can result in <strong>septic infarctions or mycotic aneurysms at the site of lodgment.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F1Wbag8.png\" width=\"992\" height=\"281\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/11/untitled-18.jpg\" alt=\"\" width=\"1000\" height=\"1245\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Large, friable, irregular vegetations on heart valves are a hallmark of infective endocarditis, characterized by the presence of bacterial colonies and significant inflammatory response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subacute Bacterial Endocarditis shows small, friable vegetations.</span></p>",
    "correct_choice_id": 41450,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10012,
    "choices": [
      {
        "id": 40014,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      },
      {
        "id": 40015,
        "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
      },
      {
        "id": 40016,
        "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
      },
      {
        "id": 40017,
        "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An electron microscopic picture of a cut section of a nerve fiber is given. What is the most commonly affected area in Guillain-Barre syndrome?&nbsp;</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/9_T4aCEI9.jpg\" alt=\"\" width=\"300\" height=\"381\"></span></p>",
    "unique_key": "Q7760619",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619205,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1&nbsp;</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The myelin sheath is <strong>most commonly</strong> affected in Guillain barre syndrome which is marked as 1 in the above image.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Guillain-Barre syndrome is acute inflammatory demyelinating polyneuropathy (AIDP).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Infections with Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, and Mycoplasma pneumoniae, or prior vaccination, have been shown to have a significant epidemiologic association with Guillain-Barr\u00e9 syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>CSF:</strong> albuminocytologic dissociation (\u2191 protein with normal WBC count).</span></li><li><span style=\"font-size:16px;\"><strong>Nerve conduction studies:</strong> slowed conduction, conduction block.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Electron microscopy identifies an early effect on myelin sheaths. The cytoplasmic processes of macrophages penetrate the basement membrane of Schwann cells stripping away the myelin sheath from the axon. Ultimately, the remnants of the myelin sheath are engulfed by the macrophages. Remyelination follows the demyelination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Label 2 \u2013 Axon:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is the axoplasm or the central axon itself.</span></li><li><span style=\"font-size:12.0pt;\">In axonal variants of GBS (such as Acute Motor Axonal Neuropathy, AMAN, and Acute Motor and Sensory Axonal Neuropathy, AMSAN), the axon is directly attacked, usually by antibodies against axonal membrane components (e.g., GM1, GD1a gangliosides).</span></li><li><span style=\"font-size:12.0pt;\">However, these variants are less common than the demyelinating type (AIDP).</span></li><li><span style=\"font-size:12.0pt;\">So while axonal involvement can occur (especially in severe or axonal variants), it is not the most common target.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Label 3 \u2013 Schwann cell nucleus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Schwann cells make and maintain the myelin sheath in the peripheral nervous system.</span></li><li><span style=\"font-size:12.0pt;\">In GBS, the immune system generally attacks the myelin sheath rather than directly killing Schwann cells or their nuclei.</span></li><li><span style=\"font-size:12.0pt;\">Damage to Schwann cells may occur secondarily, but it is not the primary target.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Label 4 \u2013 Schwann cell cytoplasm:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Similarly, the Schwann cell cytoplasm (outside the myelin) is not the main target.</span></li><li><span style=\"font-size:12.0pt;\">The immune attack focuses on the compact myelin (label 1).</span></li><li><span style=\"font-size:12.0pt;\">Schwann cells help with remyelination later but are usually not directly destroyed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture1.jpg\" alt=\"\" width=\"400\" height=\"277\"></span></p>",
    "correct_choice_id": 40014,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9930,
    "choices": [
      {
        "id": 39686,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na-EDTA</span></span></span></p>"
      },
      {
        "id": 39687,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trisodium citrate</span></span></span></p>"
      },
      {
        "id": 39688,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na-heparin</span></span></span></p>"
      },
      {
        "id": 39689,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clot activator</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the content of given vacutainer?</span> <span style=\"font-size:12.0pt\">(AIIMS MAY 2021) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/5.jpg\" style=\"height:263px; width:300px\" /></span></span></p>",
    "unique_key": "Q4046148",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619231,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;<strong>D) Clot activator</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The plastic tube shown in the given image has a red stopper, hence it contains clot activator </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red stopper plastic tubes contain silica as a clot activator. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The tubes are inverted five times to initiate the clotting process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Use &ndash; Serum Analysis, Serology tests, Blood banks</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Na-EDTA</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: EDTA is an anticoagulant used in tubes with a lavender stopper for hematological tests such as complete blood counts (CBC).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Trisodium citrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This anticoagulant is used in light blue stopper tubes, primarily for coagulation studies such as PT and APTT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Na-heparin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Heparin is an anticoagulant used in tubes with a green stopper, commonly for plasma biochemistry tests.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/6.jpg\" style=\"float:left; height:837px; width:582px\" /></span></span></span></span></p>",
    "correct_choice_id": 39689,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "InstrumentsBased"
    ]
  },
  {
    "id": 31889,
    "choices": [
      {
        "id": 127426,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti TPO antibody</span></p>"
      },
      {
        "id": 127427,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroglobulin antibody</span></p>"
      },
      {
        "id": 127428,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti Thyroid stimulating antibody</span></p>"
      },
      {
        "id": 127429,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroid receptor antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A middle aged male presented with features of neck swelling, exophthalmos, sweating, tachycardia and tremors. Which of the following is the likely associated finding in this patient? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193206.jpg\" alt=\"\" width=\"250\" height=\"398\"></span></p>",
    "unique_key": "Q2728834",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619200,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Anti thyroid receptor antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with classic signs of hyperthyroidism, including:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Neck swelling \u2192 Goiter</span></li><li><span style=\"font-size:12.0pt;\">Exophthalmos \u2192 Bulging eyes</span></li><li><span style=\"font-size:12.0pt;\">Sweating, tachycardia, tremors \u2192 Signs of increased sympathetic activity</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given history and the picture of the patient suggest a diagnosis of hyperthyroidism the commonest cause of which is <strong>Graves\u2019s disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common antibody subtype, known as thyroid-stimulating immunoglobulin (TSI), is observed in approximately 90% of patients. TSI binds to the TSH receptor and mimics its actions, stimulating adenyl cyclase and increasing the release of thyroid hormones.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti thyroid stimulating antibody cannot be the answer as such an antibody</span></li><li><span style=\"font-size:12.0pt;\">Since TSI stimulates the gland for the formation of thyroid hormones.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193354.jpg\" alt=\"\" width=\"1000\" height=\"278\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti-TPO antibody:</strong> Associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-thyroglobulin antibody:</strong> Also associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-thyroid stimulating antibody:</strong> Incorrect terminology for TSI, which is already covered under anti-thyroid receptor antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves' disease is associated with anti-thyroid receptor antibodies (TSI), which stimulate the thyroid gland to produce excess thyroid hormones, leading to hyperthyroidism. The presence of neck swelling, exophthalmos, and other hyperthyroid symptoms strongly suggests this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves Disease \u2013 Key Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KgbS7tT.png\" width=\"1030\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins 10<sup>th</sup>/ 1081</strong></span></p>",
    "correct_choice_id": 127429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10432,
    "choices": [
      {
        "id": 41694,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transferrin saturation</span></span></span></p>"
      },
      {
        "id": 41695,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RBC protoporphyrin</span></span></span></p>"
      },
      {
        "id": 41696,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total iron binding capacity</span></span></span></p>"
      },
      {
        "id": 41697,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum transferrin receptors &nbsp;</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In iron deficiency anemia all of the following is increased except? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q4016477",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619228,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Transferrin saturation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transferrin Saturation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the percentage of transferrin (the protein that transports iron in the blood) that is saturated with iron. In iron deficiency anemia, the transferrin saturation is decreased because there is less iron available to bind to transferrin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is important to note that in a patient with iron deficiency anemia, there is increased TIBC as well as increased RBC Protoporphyrin levels and the number of serum transferrin receptors. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. RBC protoporphyrin</span></strong><span style=\"font-size:12.0pt\">: This is a precursor in the heme synthesis pathway. In iron deficiency anemia, the lack of iron means that protoporphyrin accumulates, as it cannot be converted into heme. Therefore, RBC protoporphyrin levels are increased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Total iron binding capacity (TIBC)</span></strong><span style=\"font-size:12.0pt\">: This is a measure of the total capacity of the blood to bind iron with transferrin. In iron deficiency anemia, TIBC is increased as the body produces more transferrin in an attempt to capture more iron from the diet and the body&rsquo;s stores.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum transferrin receptors</span></strong><span style=\"font-size:12.0pt\">: These receptors are present on the surface of cells and are involved in the uptake of transferrin-bound iron. In iron deficiency anemia, the number of these receptors increases as the body tries to increase iron uptake from the blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/11/untitled-24.jpg\" style=\"height:568px; width:1000px\" /></p>",
    "correct_choice_id": 41694,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9815,
    "choices": [
      {
        "id": 39227,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BTK</span></span></span></p>"
      },
      {
        "id": 39228,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">JAK-3</span></span></span></p>"
      },
      {
        "id": 39229,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RAG1</span></span></span></p>"
      },
      {
        "id": 39230,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL-7Ra</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which gene is not involved in SCID? (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q6627499",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619239,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) BTK</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BTK mutation causes X-linked agammaglobulinemia and not SCID&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(severe combined immunodeficiency).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe combined immunodeficiency is a defect in both humoral and cell-mediated immune responses.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In this condition, the following genes are involved:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. JAK3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mutations in the JAK3 gene are associated with an autosomal recessive form of SCID. JAK3 is essential for the signaling pathways of multiple cytokine receptors, including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, which are crucial for lymphocyte development and function.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.&nbsp; RAG1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The RAG1 gene, along with RAG2, is crucial for V(D)J recombination, which is necessary for the generation of diverse antigen receptors on B cells and T cells. Mutations in RAG1 can lead to SCID due to the inability to produce functional B and T cells.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. IL-7Ra</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The IL-7 receptor alpha chain (IL-7Ra) is important for T-cell development. Mutations in IL-7Ra can lead to a T- B+ NK+ form of SCID, where T cells are absent or non-functional, but B cells and natural killer cells are present.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Persons with SCID are extremely susceptible to recurrent, severe infections by a wide range of pathogens, including:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Candida albicans</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pneumocystis jiroveci</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pseudomonas</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cytomegalovirus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varicella</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SCID is caused by mutations in several different genes</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">JAK3</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RAG1</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-7Ra</span></em></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg 438-439</span></strong></span></span></p>",
    "correct_choice_id": 39227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 14633,
    "choices": [
      {
        "id": 58493,
        "text": "<p><span style=\"font-size:12.0pt;\">Kupffer cells</span></p>"
      },
      {
        "id": 58494,
        "text": "<p><span style=\"font-size:12.0pt;\">Dust cells</span></p>"
      },
      {
        "id": 58495,
        "text": "<p><span style=\"font-size:12.0pt;\">Ito cell</span></p>"
      },
      {
        "id": 58496,
        "text": "<p><span style=\"font-size:12.0pt;\">Mesangial cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Organisms entering via enteric route into our body are countered by which cells of the liver? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q2390271",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619211,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kupffer cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kupffer cells are specialized macrophages of the liver that are responsible for the destruction of bacterial foreign bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pathogenesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Organisms</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enteric Route</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Portal Vein</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp; Kupffer Cells (Liver Macrophages)</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp; Phagocytosis and Destruction</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;Activation of Immune Response</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">Recruitment of Other Immune Cells</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp; Clearance of Pathogens</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u2193</span></p><p><span style=\"font-size:12.0pt;\">&nbsp; Prevention of Dissemination</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Dust cells:</strong> These are alveolar macrophages found in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ito cells:</strong> These cells are concerned with the storage of vitamin A and are located in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Mesangial cells:</strong> These cells are found in the kidneys and support glomerular capillaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Kupffer cells are the liver macrophages responsible for countering organisms entering the body via the enteric route.</span></p>",
    "correct_choice_id": 58493,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 65199,
    "choices": [
      {
        "id": 259973,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency</span></p>"
      },
      {
        "id": 259974,
        "text": "<p><span style=\"font-size:12.0pt;\">Folate deficiency</span></p>"
      },
      {
        "id": 259975,
        "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine deficiency</span></p>"
      },
      {
        "id": 259976,
        "text": "<p><span style=\"font-size:12.0pt;\">Niacin deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old male patient presents with fatigue, glossitis, and a burning sensation in his mouth. Peripheral blood smear reveals macrocytes and hypersegmented neutrophils. Laboratory studies show normal vitamin B12 levels. What is the likely diagnosis in this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q5900749",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619222,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Folate deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient\u2019s symptoms, including fatigue and glossitis, along with the presence of <strong>macrocytic anemia</strong> (macrocytes and hypersegmented neutrophils on peripheral smear) and <strong>low serum folate levels</strong>, strongly suggest <strong>folate deficiency</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin B12 deficiency:</strong> Incorrect. Although vitamin B12 deficiency also causes megaloblastic anemia, the absence of neurological symptoms (e.g., paresthesias, ataxia) and normal vitamin B12 levels make this less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyridoxine deficiency:</strong> Incorrect. Pyridoxine deficiency is associated with sideroblastic anemia, not megaloblastic anemia, and does not involve macrocytes or hypersegmented neutrophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Niacin deficiency:</strong> Incorrect. Niacin deficiency presents as pellagra (dermatitis, diarrhea, dementia), not megaloblastic anemia or glossitis with macrocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Folate deficiency</strong> is a common cause of <strong>megaloblastic anemia</strong> and is characterized by macrocytes, hypersegmented neutrophils, and low serum folate levels. It typically presents with <strong>anemia and glossitis</strong> but lacks the neurological symptoms associated with vitamin B12 deficiency.</span></p>",
    "correct_choice_id": 259974,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 9777,
    "choices": [
      {
        "id": 39075,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">APTT</span></span></span></p>"
      },
      {
        "id": 39076,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PT</span></span></span></p>"
      },
      {
        "id": 39077,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TT</span></span></span></p>"
      },
      {
        "id": 39078,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleeding time</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which test evaluates the extrinsic pathway?</span></span> (AIIMS MAY 2019)</p>",
    "unique_key": "Q9620648",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619223,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) PT</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prothrombin time (PT) evaluates the extrinsic pathway of coagulation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PT measures the clotting time of plasma in the presence of an optimal concentration of tissue extract (thromboplastin). This indicates the overall efficiency of the extrinsic clotting system.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/930.jpg\" style=\"height:456px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of prolonged PT:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of oral anticoagulant drugs - vitamin K antagonists</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liver disease - obstructive jaundice</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin K deficiency</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disseminated intravascular coagulation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Previously undiagnosed factor VII, X, V or prothrombin deficiency or defect (rare)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activated partial thromboplastin time (APTT) measures the clotting time of plasma after the activation of contact factors and the addition of phospholipid and CaCl2, but without added tissue thromboplastin. It indicates the overall efficiency of the intrinsic pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of prolonged APTT:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disseminated intravascular coagulation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liver disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Massive transfusion with plasma-depleted red blood cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of or contamination with heparin or other anticoagulants</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A circulating anticoagulant (inhibitor)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deficiency of a coagulation factor other than factor VII</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intake of oral anticoagulant drugs</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin K deficiency</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. APTT (Activated Partial Thromboplastin Time)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: APTT evaluates the intrinsic pathway of the coagulation cascade. It measures the time taken for plasma to clot after the activation of contact factors and the addition of phospholipid and calcium, but without tissue thromboplastin. APTT is used to assess the intrinsic pathway involving factors XII, XI, IX, and VIII, as well as the common pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. TT (Thrombin Time)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TT measures the final step of the coagulation process&mdash;conversion of fibrinogen to fibrin after the addition of thrombin. It does not evaluate either the intrinsic or extrinsic pathways specifically but rather the conversion of fibrinogen to fibrin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Bleeding time</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Bleeding time is a test that assesses platelet function and the initial phase of hemostasis but does not evaluate the coagulation pathways.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prothrombin time (PT) evaluates the extrinsic pathway of the coagulation cascade by measuring the time it takes for plasma to clot after the addition of tissue thromboplastin and calcium. It is commonly prolonged in conditions such as vitamin K deficiency, liver disease, and the use of vitamin K antagonists.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic Basis of disease, 8<sup>th</sup> edition, Pg 232</span></strong></span></span></p>",
    "correct_choice_id": 39076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 31890,
    "choices": [
      {
        "id": 127430,
        "text": "<p><span style=\"font-size:12.0pt;\">High Ki67+</span></p>"
      },
      {
        "id": 127431,
        "text": "<p><span style=\"font-size:12.0pt;\">ER+</span></p>"
      },
      {
        "id": 127432,
        "text": "<p><span style=\"font-size:12.0pt;\">BRCA 1 +</span></p>"
      },
      {
        "id": 127433,
        "text": "<p><span style=\"font-size:12.0pt;\">P53 +</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a good prognostic factor for breast cancer patients? (NEET PG 2023)</span></p>",
    "unique_key": "Q5062908",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619201,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) ER+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ER+ is a good prognostic factor for breast cancer patients as it is seen with luminal A and B subtypes of the breast cancer.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. High Ki67+:&nbsp;</strong>High Ki67+ indicates a high proliferative index, which is associated with more aggressive tumors and a poorer prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. BRCA1+:&nbsp;</strong>BRCA1 mutation is associated with an increased risk of developing breast and ovarian cancers, and these cancers tend to be more aggressive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. P53+:&nbsp;</strong>P53 mutations are associated with a variety of cancers and typically indicate a poorer prognosis due to the loss of normal p53 tumor suppressor function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ER-positive status in breast cancer is a good prognostic factor because it indicates a slower-growing tumor that is likely to respond well to hormone therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Why ER\u207a is a Good Prognostic Factor:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Slower tumor growth:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">ER\u207a tumors tend to grow more slowly than ER\u207b tumors.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Better treatment response:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">ER\u207a cancers respond well to hormonal therapies such as:</span></li><li><span style=\"font-size:12.0pt;\">Tamoxifen</span></li><li><span style=\"font-size:12.0pt;\">Aromatase inhibitors</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Lower recurrence risk:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hormone receptor\u2013positive cancers have a lower risk of early recurrence.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Overall survival:</span><ul><li><span style=\"font-size:12.0pt;\">Patients with ER\u207a tumors generally have better overall survival.</span></li></ul></li></ol>",
    "correct_choice_id": 127431,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9848,
    "choices": [
      {
        "id": 39358,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Transfusion reaction</span></span></span></p>"
      },
      {
        "id": 39359,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute adrenal crisis</span></span></span></p>"
      },
      {
        "id": 39360,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Fat embolism</span></span></span></p>"
      },
      {
        "id": 39361,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hemorrhagic shock</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 24-year-old man met with an road traffic accident and was brought to the casualty after 6 hours. His B.P. was 90/60 mm Hg, heart rate was 110/min, and Sp02 was 92%. A blood transfusion was done. After a few hours, the patient is febrile, tachypneic, and starts bleeding from the IV and NG tube sites. His SpO2 levels started falling. What could be the cause? (AIIMS MAY 2020)</span></span></span></p>",
    "unique_key": "Q3021124",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619254,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Transfusion reaction</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Given the clinical scenario the most likely diagnosis is acute hemolytic transfusion reaction causing DIC (disseminated intravascular coagulation) resulting in bleeding from IV catheter and nasogastric tube within a few hours of blood transfusion.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute Hemolytic Transfusion reaction</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Immune-mediated hemolysis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Preformed antibodies</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> in recipient lyse donor erythrocytes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Complement-mediated lysis occurs causing <strong>intravascular hemolysis and hemoglobinuria</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Severe cases, tissue factor released from the lysed erythrocytes may <strong>initiate DIC</strong>, which is a consumptive coagulopathy with bleeding manifestations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other complications include <strong>shock, acute kidney injury, and sometimes, death.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The various blood transfusion reactions according to their time of occurrence are as follows:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Anaphylactic reaction</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> - Within a few seconds to minutes of the transfusion. Common in <strong>selective IgA deficiency patients.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Allergic/Urticarial reactions - Within 2-3 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute hemolytic transfusion reaction (AHTR) - Within 24 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Febrile <strong>non-hemolytic</strong> transfusion reaction (FNHT) - Within 6 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Delayed hemolytic transfusion reaction (DHTR) - After 24 hours of transfusion</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong>TRALI vs TACO:</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-132115.png\" style=\"height:429px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">TRALI: transfusion-related acute lung injury, TACO: Transfusion-associated cardiac overload, CXR: chest X-ray, BNP: B type natriuretic peptide, PAOP: pulmonary artery occluding pressure.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Acute adrenal crisis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves sudden adrenal insufficiency, leading to hypotension, shock, and electrolyte imbalances. It would not typically cause the specific symptoms of hemolysis and DIC seen in this case.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fat embolism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Fat embolism syndrome can occur after long bone fractures, presenting with respiratory distress, neurological symptoms, and petechiae. However, it typically occurs within 24-72 hours after injury and is not directly associated with blood transfusions.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hemorrhagic shock</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Hemorrhagic shock results from significant blood loss, leading to hypotension and tachycardia. While this could be a consideration, the transfusion reaction and subsequent DIC better explain the patient&#39;s clinical presentation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An acute hemolytic transfusion reaction (AHTR) can lead to disseminated intravascular coagulation (DIC), characterized by rapid onset of fever, bleeding from multiple sites, and hemolysis shortly after a blood transfusion.</span></span></span></p>",
    "correct_choice_id": 39358,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14635,
    "choices": [
      {
        "id": 58501,
        "text": "<p><span style=\"font-size:12.0pt;\">Fecal Lactoferrin</span></p>"
      },
      {
        "id": 58502,
        "text": "<p><span style=\"font-size:12.0pt;\">Procalcitonin</span></p>"
      },
      {
        "id": 58503,
        "text": "<p><span style=\"font-size:12.0pt;\">Tissue Trans Glutaminase</span></p>"
      },
      {
        "id": 58504,
        "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the marker of intestinal inflammation? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q7848156",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619212,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) fecal lactoferrin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fecal lactoferrin is a highly sensitive and specific marker for detecting intestinal inflammation. It is commonly used as a marker for inflammatory bowel disease (IBD) and is useful in differentiating IBD from irritable bowel syndrome (IBS), which does not typically involve inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Procalcitonin:</strong> This is an acute-phase reactant produced primarily in the liver and used as a marker for bacterial infections and sepsis, not specifically for intestinal inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tissue Transglutaminase:</strong> This test is used in the screening for celiac disease, which is an autoimmune disorder affecting the small intestine but not a direct marker of inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Albumin:</strong> Albumin is a protein produced by the liver and is a marker for liver function and nutritional status but not specific for intestinal inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fecal lactoferrin is a highly sensitive and specific marker for detecting intestinal inflammation and is used to diagnose and monitor inflammatory bowel disease.</span></p>",
    "correct_choice_id": 58501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "InvestigationBased"
    ]
  },
  {
    "id": 10068,
    "choices": [
      {
        "id": 40238,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-b, 2-d, 3-a, 4-c</span></span></span></p>"
      },
      {
        "id": 40239,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-a, 2-d, 3-c, 4-b</span></span></span></p>"
      },
      {
        "id": 40240,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-b, 2-d, 3-c, 4-a</span></span></span></p>"
      },
      {
        "id": 40241,
        "text": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-c, 2-d, 3-a, 4-b</span></span></span></p>"
      }
    ],
    "text": "<p style=\"margin-right:-64px\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following microscopic finding with the type of tumor?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"margin-right:-64px\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-110509.jpg\" style=\"height:193px; width:700px\" /></p>",
    "unique_key": "Q3751900",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619237,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) 1-c, 2-d, 3-a, 4-b </strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-112120.jpg\" style=\"height:944px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-111041.jpg\" style=\"height:284px; width:1000px\" /></p>",
    "correct_choice_id": 40241,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 24748,
    "choices": [
      {
        "id": 98953,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 only</span></span></span></p>"
      },
      {
        "id": 98954,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 only</span></span></span></p>"
      },
      {
        "id": 98955,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 and 3</span></span></span></p>"
      },
      {
        "id": 98956,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2 and 3</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Under which circumstances is live vaccination not contraindicated?</span> (<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">INICET MAY 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DiGeorge syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wiskott Aldrich Syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ataxia telangiectasia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complement deficiency</span></span></span></li>\r\n</ol>",
    "unique_key": "Q4953792",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619213,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) 4 only</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Live vaccinations are generally contraindicated in individuals with certain immunodeficiency disorders because their immune systems may not be able to handle the attenuated (weakened) pathogens in the vaccines, potentially leading to severe infections. However, there are exceptions based on the nature of the immunodeficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Complement deficiency:</span></strong><span style=\"font-size:12.0pt\"> This is a condition where components of the complement system (a part of the immune system) are deficient. Complement deficiencies do not affect the cellular immune response significantly, meaning that the risk of adverse effects from live vaccinations is not increased. Therefore, individuals with complement deficiency can receive live vaccines safely.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. DiGeorge syndrome</span></strong><span style=\"font-size:12.0pt\">: DiGeorge syndrome involves a defect in T-cell production due to thymic hypoplasia. Since T-cells are crucial for mounting an immune response to vaccines, live vaccines are contraindicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ataxia telangiectasia</span></strong><span style=\"font-size:12.0pt\">: This is a condition characterized by defects in both the immune system and DNA repair mechanisms. Patients with this condition have a higher risk of developing severe infections from live vaccines, so they are contraindicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Wiskott-Aldrich Syndrome</span></strong><span style=\"font-size:12.0pt\">: This is an X-linked recessive disorder affecting both the immune system and platelet production. Individuals with Wiskott-Aldrich Syndrome are at risk for severe infections from live vaccines due to their compromised immune function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complement deficiency does not pose a contraindication for live vaccination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, it is important to note that live vaccines should be avoided in individuals with DiGeorge syndrome, Wiskott-Aldrich Syndrome, and Ataxia telangiectasia, because these are immunodeficiency disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256118.jpg\" style=\"height:1286px; width:1000px\" /></span></span></span></span></p>",
    "correct_choice_id": 98953,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 47542,
    "choices": [
      {
        "id": 189779,
        "text": "<p><span style=\"font-size:12.0pt;\">ALL</span></p>"
      },
      {
        "id": 189780,
        "text": "<p><span style=\"font-size:12.0pt;\">AML</span></p>"
      },
      {
        "id": 189781,
        "text": "<p><span style=\"font-size:12.0pt;\">CML</span></p>"
      },
      {
        "id": 189782,
        "text": "<p><span style=\"font-size:12.0pt;\">CLL</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female came with early satiety, massive splenomegaly, petechiae, and bleeding gums. Her hemoglobin was 8 gm/dl and TLC was 85,000/mm3. Which of the following is the diagnosis?&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q2620028",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619225,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) CML</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and laboratory findings are highly suggestive of chronic myelogenous leukemia (CML).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient, a 20-year-old female, presents with early satiety, which can be attributed to the massive splenomegaly. An enlarged spleen can compress the stomach, leading to a feeling of early satiety. Massive splenomegaly is a characteristic feature of CML, resulting from the infiltration of the spleen by leukemic cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of petechiae and bleeding gums indicates thrombocytopenia, which is a common finding in CML patients. Thrombocytopenia can be caused by the decreased production of platelets due to the crowding out of normal hematopoietic cells by the leukemic cells in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's hemoglobin level of 8 gm/dl suggests anemia, another common finding in CML. Anemia in CML can be due to the ineffective erythropoiesis caused by the abnormal proliferation of myeloid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most striking finding is the markedly elevated total leukocyte count (TLC) of 85,000/mm3, which is highly indicative of CML. In CML, there is a characteristic uncontrolled proliferation of myeloid cells, leading to a significant increase in the white blood cell count.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ALL (Acute Lymphoblastic Leukemia):&nbsp;</strong>ALL is more common in pediatric patients and typically presents with hepatosplenomegaly, lymphadenopathy, and bone tenderness. The extremely high TLC and massive splenomegaly are more suggestive of CML than ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. AML (Acute Myelogenous Leukemia):&nbsp;</strong>AML can present with gum hyperplasia, the presence of myeloblasts with granular cytoplasm, or <strong>Auer rods</strong> (rod-shaped or needle-shaped crystals). The chronic nature of the presentation and the massive splenomegaly are more consistent with CML.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-152749.png\" alt=\"\" width=\"600\" height=\"299\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CLL (Chronic Lymphocytic Leukemia):&nbsp;</strong>CLL is more common in older adults and typically presents with lymphadenopathy, hepatosplenomegaly, and a high lymphocyte count. The high TLC with myeloid predominance and the absence of significant lymphadenopathy make CML a more likely diagnosis than CLL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic myelogenous leukemia (CML) should be strongly suspected in a patient presenting with <strong>massive splenomegaly</strong>, <strong>early satiety, thrombocytopenia, anemia, and a markedly elevated total leukocyte count with myeloid predominance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of the Philadelphia chromosome, resulting from the reciprocal translocation between chromosomes 9 and 22, is the hallmark genetic abnormality in CML.</span></p>",
    "correct_choice_id": 189781,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 10283,
    "choices": [
      {
        "id": 41098,
        "text": "<p><span style=\"font-size:12.0pt;\">Allograft rejection</span></p>"
      },
      {
        "id": 41099,
        "text": "<p><span style=\"font-size:12.0pt;\">Allograft arteriopathy</span></p>"
      },
      {
        "id": 41100,
        "text": "<p><span style=\"font-size:12.0pt;\">Infection</span></p>"
      },
      {
        "id": 41101,
        "text": "<p><span style=\"font-size:12.0pt;\">Malignancy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The single most important long-term limitation of cardiac transplantation is: (NEET PG 2018)</span></p>",
    "unique_key": "Q7390939",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619204,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Allograft arteriopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The single most important long-term limitation of cardiac transplantation is allograft arteriopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allograft arteriopathy: It is the single most important long-term limitation for cardiac transplantation. It is a late, progressive, diffusely stenosing intimal proliferation in the coronary arteries, leading to ischemic injury. It can lead to silent myocardial infarction since transplant patients have denervated hearts and do not experience angina. Progressive congestive heart failure and sudden cardiac death can also occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Complications following cardiac transplantation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Allograft rejection</strong>: It is the primary concern that requires close surveillance. Both classic cellular rejection and antibody-mediated rejection is recognized. Cellular rejection is characterized by interstitial lymphocytic inflammation, with associated myocyte damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Infection</strong>: Infection is common in organ transplant recipients. Bacteria and viruses account for more than 80% of infections after transplantation. The most common bacterial infections early after transplantation are nosocomial, caused by infected intravascular catheters or lines, or gram-negative pneumonias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Renal dysfunction</strong>- Immunosuppressive therapy with calcineurin inhibitors has improved both graft function and survival in heart transplantation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Malignancy</strong>: Following heart transplantation, malignancy is identified in 3% to 18% of the recipients, with an estimated risk of 1% to 2% per year. It ranks second to coronary vasculopathy as a major cause of mortality, accounting for 10% to 23% of all deaths following heart transplantation. Cutaneous malignancy is the most common type with a predominance of squamous cell carcinoma. Post-transplantation lymphoproliferative disorder (PTLD) is a frequently fatal complication, the peak occurrence of PTLD is 3 to 4 months after transplantation. A strong association of PTLD with Epstein-Barr virus has been observed in several series.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allograft arteriopathy is the foremost long-term limitation in cardiac transplantation, causing significant morbidity and mortality through progressive coronary stenosis.</span></p>",
    "correct_choice_id": 41099,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10492,
    "choices": [
      {
        "id": 41934,
        "text": "<p><span style=\"font-size:12.0pt;\">Glioblastoma multiforme</span></p>"
      },
      {
        "id": 41935,
        "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma</span></p>"
      },
      {
        "id": 41936,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-Hodgkin lymphoma</span></p>"
      },
      {
        "id": 41937,
        "text": "<p><span style=\"font-size:12.0pt;\">Non seminomatous germ cell tumor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient presented with scrotal swelling and ataxia. Which among the following could likely be a cause? (AIIMS NOV 2021)</span></p>",
    "unique_key": "Q4695411",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619257,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Non-Hodgkin lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This was an atypical question, which is important only if it is repeated in a subsequent exam.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely cause in the following case is <strong>Non-Hodgkin lymphoma (NHL) - Diffuse Large B cell lymphoma (DLBCL) type.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diffuse large B-cell lymphoma (<strong>DLBCL) is the most common form of NHL.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The median patient age is about 60 years, but DLBCL also occurs in young adults and children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DLBCL commonly presents with enlarged lymph nodes or rapidly growing mass along with B symptoms, which include fever, night sweats, and weight loss. The B symptoms can be seen in 30% of the patients. Bone marrow involvement is more common in indolent disease and can be seen in up to 50% of the cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">About 50% of the patients have extranodal involvement like stomach or gastrointestinal tract (most common primary extranodal site), skin, bones, spinal cord, testicles, among other locations. Renal involvement can be secondary to bulky disease or lymphadenopathy, causing a ureteral obstruction or due to tumor lysis syndrome. DLBCL can also present with symptoms suggestive of superior vena cava syndrome, compression of the airways. The symptoms can be related to the infiltrated organ if the disease spreads beyond the lymphatics in so-called extranodal disease. A variety of paraneoplastic syndromes may also be associated with B cell lymphomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metastasis involves the central nervous system (CNS), skin, contralateral testis, and pleura resulting in local complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Even though ataxia is seen as a paraneoplastic symptom due to cerebellar degeneration in Hodgkin lymphoma, testicular involvement is very rare</strong> and so far, only 5 cases have been reported. Hodgkin lymphoma arises in a single node or chain of nodes and spreads first to anatomically contiguous lymphoid tissues. The extranodal presentation is rare. The extranodal disease can occur at any site like lung, liver, bone, and bone marrow is most common if it occurs. The central nervous system and the testis are exceptionally rare sites for Hodgkin's lymphoma. Thus Hodgkin's lymphoma can be ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Glioblastoma multiforme</strong>: Most common sites are the frontal and temporal lobes. <strong>Extracranial metastases of malignant gliomas are extremely rare</strong> due to absence of a lymphatic system in the brain and spinal cord for systemic dissemination, dense dura around intracranial veins and lack of nurturing stroma in other organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-396.jpg\" alt=\"\" width=\"300\" height=\"375\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hodgkin\u2019s Lymphoma: </strong>Doesn\u2019t involve the extra nodal sites</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Non-seminomatous germ cell tumor</strong>: These tumors primarily metastasize to the lungs, liver, CNS, and bone, in order of frequency. Although CNS involvement can occur, it is relatively rare. The combination of scrotal swelling and ataxia is less typical for non-seminomatous germ cell tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Non-Hodgkin lymphoma (NHL), particularly Diffuse Large B-Cell Lymphoma (DLBCL),</strong> is a likely cause of scrotal swelling and ataxia due to its potential for extranodal involvement and associated paraneoplastic syndromes.</span></p>",
    "correct_choice_id": 41936,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 50666,
    "choices": [
      {
        "id": 202202,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-nuclear antibody</span></p>"
      },
      {
        "id": 202203,
        "text": "<p><span style=\"font-size:12.0pt;\">SCL-70 antibody</span></p>"
      },
      {
        "id": 202204,
        "text": "<p><span style=\"font-size:12.0pt;\">U1-RNP antibody</span></p>"
      },
      {
        "id": 202205,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-CCP antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antibodies is diagnostic for mixed connective tissue disease? (NEET PG 2016)</span></p>",
    "unique_key": "Q2811106",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619247,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. U1-RNP antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mixed connective tissue disease is characterized by high titers of antibodies to U1 ribonucleoprotein (U1-RNP). This antibody is considered diagnostic for the condition, which presents with clinical features that overlap with those of SLE, systemic sclerosis, and polymyositis. Patients typically present with synovitis of the fingers, Raynaud phenomenon, myositis, and renal involvement, which usually responds well to corticosteroids, at least in the short term.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti-nuclear antibody</strong> - While anti-nuclear antibodies (ANAs) are present in mixed connective tissue disease, they are not specific for this condition. ANAs are found in many autoimmune diseases including SLE, systemic sclerosis, and Sj\u00f6gren syndrome, so their presence alone cannot differentiate mixed connective tissue disease from other connective tissue disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. SCL-70 antibody</strong> - SCL-70 antibody (anti-DNA topoisomerase I) is associated with systemic sclerosis (scleroderma), particularly the diffuse cutaneous form with increased risk of pulmonary fibrosis and peripheral vascular disease. It is not characteristic of mixed connective tissue disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti-CCP antibody</strong> - Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for rheumatoid arthritis. They are not typically found in mixed connective tissue disease and are used to differentiate rheumatoid arthritis from other forms of inflammatory arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High titres of antibodies to U1 ribonucleoprotein (U1-RNP) are the serological hallmark and diagnostic marker for mixed connective tissue disease, a condition with overlapping features of several autoimmune disorders including SLE, systemic sclerosis, and polymyositis.</span></p>",
    "correct_choice_id": 202204,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9968,
    "choices": [
      {
        "id": 39838,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymphoma</span></p>"
      },
      {
        "id": 39839,
        "text": "<p><span style=\"font-size:12.0pt;\">Leishmaniasis</span></p>"
      },
      {
        "id": 39840,
        "text": "<p><span style=\"font-size:12.0pt;\">Urate nephropathy</span></p>"
      },
      {
        "id": 39841,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male presented with a history of intractable diarrhea. Based on the histological image shown below which of the following is the most appropriate diagnosis:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/47.jpg\" alt=\"\" width=\"450\" height=\"286\"></span></p>",
    "unique_key": "Q9467043",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619252,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical history with <strong>Russel bodies</strong> on histology points to the diagnosis of multiple myeloma. The image shows Russell bodies which are eosinophilic, large, homogeneous immunoglobulin-containing inclusions usually found in a plasma cell undergoing excessive synthesis of immunoglobulins. <strong>Russell bodies (INTRACYTOPLASMIC) are distended <u>endoplasmic reticulum</u></strong><u>.</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple myeloma usually presents as destructive plasma cell tumors (plasmacytomas) involving the axial skeleton.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Malignant plasma cells have a perinuclear clearing due to a prominent Golgi apparatus and an eccentrically placed nucleus. Relatively normal appearing plasma cells, plasmablasts with vesicular nuclear chromatin and a prominent single nucleolus, or bizarre, multinucleated cells may predominate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other cytologic variants stem from the dysregulated synthesis and secretion of Ig, which often leads to intracellular accumulation of intact or partially degraded protein.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Such variants include \u2013</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Flame cells</strong> with fiery red cytoplasm</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/48.jpg\" alt=\"\" width=\"300\" height=\"226\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mott cells</strong> with multiple grapelike cytoplasmic droplets and cells containing a variety of other inclusions, including fibrils, crystalline rods, and globules.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/49.jpg\" alt=\"\" width=\"300\" height=\"263\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/50.jpg\" alt=\"\" width=\"300\" height=\"224\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Lymphoma:</strong> Lymphomas are malignancies of lymphoid cells, and while they can involve plasma cells, the presence of Russell bodies and the clinical history provided is more consistent with multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Leishmaniasis:</strong> Leishmaniasis is a parasitic infection caused by protozoa of the genus Leishmania. It typically does not present with Russell bodies or the plasma cell abnormalities seen in multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Urate nephropathy:</strong> Urate nephropathy involves the deposition of uric acid crystals in the kidneys, leading to kidney damage. This condition does not present with the histological features or clinical history described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Russell bodies in plasma cells, along with a clinical history of intractable diarrhea (suggestive of increased risk of infections due to nonfunctional antibodies), strongly suggests a diagnosis of multiple myeloma, a malignancy characterized by the abnormal proliferation of plasma cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease, Page No. 1126</strong></span></p>",
    "correct_choice_id": 39841,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 10433,
    "choices": [
      {
        "id": 41698,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&beta;-2 microglobulin</span></span></span></p>"
      },
      {
        "id": 41699,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium levels</span></span></span></p>"
      },
      {
        "id": 41700,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum creatinine</span></span></span></p>"
      },
      {
        "id": 41701,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protein levels</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a poor prognostic marker of multiple myeloma? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q2892617",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619229,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans. A)</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>&beta;-2 microglobulin</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&beta;-2 microglobulin is a poor prognostic marker of multiple myeloma.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple myeloma is a plasma cell neoplasm commonly associated with lytic bone lesions, hypercalcemia, renal failure, and acquired immune abnormalities.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CRAB criteria for MM </span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypercalcemia: serum calcium &gt;11mg/dl </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">renal Insufficiency: serum creatinine &gt;2 mg/dl or creatinine clearance &lt;40 ml/min </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemia: Hgb &lt;10 g/dl </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lytic bone lesions </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/10_J5SuwJl.jpg\" style=\"height:216px; width:324px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Poor prognostic factors for multiple myeloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum <strong>Beta 2-microglobulin - It is the single most powerful predictor</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deletion of 17&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pITP53 sequences and the <strong>translocations t (14;16) and t(14;20)</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">serum Immunoglobulins</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated lactate dehydrogenase</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High C-reactive protein</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased plasma cell proliferative activity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High degree of bone marrow replacement</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of plasmablastic morphology</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated serum soluble receptor for IL6</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcium levels:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Elevated calcium levels are part of the CRAB criteria and indicate disease activity, but are not as strong a prognostic marker as &beta;-2 microglobulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum creatinine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Increased serum creatinine is also part of the CRAB criteria and indicates renal involvement, but it is not the single most powerful predictor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Protein levels:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Protein levels can be elevated due to monoclonal proteins produced by myeloma cells, but again, they are not as powerful a prognostic marker as &beta;-2 microglobulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&beta;-2 microglobulin is the single most powerful predictor of poor prognosis in multiple myeloma, reflecting the tumor burden and the rate of disease progression.</span></span></span></p>",
    "correct_choice_id": 41698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54941,
    "choices": [
      {
        "id": 219225,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic calcification with normal serum Ca\u00b2\u207a levels</span></p>"
      },
      {
        "id": 219226,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic calcification with increased serum Ca\u00b2\u207a levels</span></p>"
      },
      {
        "id": 219227,
        "text": "<p><span style=\"font-size:12.0pt;\">Dystrophic calcification with normal serum Ca\u00b2\u207a levels</span></p>"
      },
      {
        "id": 219228,
        "text": "<p><span style=\"font-size:12.0pt;\">Dystrophic calcification with increased serum Ca\u00b2\u207a levels</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old female presents with cervical lymphadenopathy and fever. The biopsy has revealed granulomatous necrotizing inflammation. Which of the following is the likely finding with this presentation? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q1947697",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619207,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Dystrophic calcification with normal serum Ca\u00b2\u207a levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient described has a granulomatous necrotizing inflammation, which is highly suggestive of tuberculosis, particularly in regions where tuberculosis is prevalent. Tuberculosis often leads to the formation of caseating granulomas, which can undergo dystrophic calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dystrophic calcification occurs in areas of tissue damage or necrosis, such as caseating granulomas in tuberculosis. This type of calcification is characterized by the <strong>deposition of calcium salts in dead or degenerating tissues,</strong> and importantly, it occurs despite normal serum calcium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, metastatic calcification occurs in normal tissues and is associated with hypercalcemia, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metastatic calcification with normal serum Ca\u00b2\u207a levels:</strong> Metastatic calcification is not associated with normal calcium levels. It is typically associated with elevated serum calcium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metastatic calcification with increased serum Ca\u00b2\u207a levels:</strong> While metastatic calcification does occur with increased serum calcium levels, it is not related to granulomatous necrotizing inflammation like that seen in tuberculosis. This is seen in Sarcoidosis, parathyroid adenoma, chronic kidney disease, William syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dystrophic calcification with increased serum Ca\u00b2\u207a levels:</strong> Dystrophic calcification occurs in the context of normal serum calcium levels, not increased levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dystrophic calcification is a common finding in tissues undergoing necrosis, such as in caseating granulomas in tuberculosis, and it occurs with normal serum calcium levels.</span></p>",
    "correct_choice_id": 219227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 54504,
    "choices": [
      {
        "id": 217485,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-a, 3-d, 4-b</span></span></span></p>"
      },
      {
        "id": 217486,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-b, 2-c, 3-d,4-a</span></span></span></p>"
      },
      {
        "id": 217487,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-b, 3-d, 4-a</span></span></span></p>"
      },
      {
        "id": 217488,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-a,&nbsp; 2-b, 3-c, 4-d</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Match the following blood components with their shelf life:&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/screenshot-2024-08-23-123037.png\" style=\"height:278px; width:1000px\" /></span></span></span></p>",
    "unique_key": "Q8717299",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619248,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A)</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> 1-c, 2-a, 3-d, 4-b</span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shelf life of blood components varies depending on their storage conditions and preservation methods. Here&#39;s a detailed explanation of the correct matches:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelets</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 5 days when stored with continuous agitation to prevent clumping. This is essential to maintain the efficacy and viability of the platelets.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Packed RBC</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 42 days when stored in a preservative solution containing saline, adenine, glucose, and mannitol (SAGM). This extends the shelf life while maintaining the quality of the red blood cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryoprecipitate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 1 year when stored at temperatures below -18&deg;C. Cryoprecipitate is used for patients with clotting factor deficiencies, such as hemophilia A and von Willebrand disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Granulocytes concentrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 24 hours. This component contains white blood cells and is used for patients with severe neutropenia, such as those with febrile neutropenia or aplastic anemia.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelets have a shelf life of 5 days, packed RBCs 42 days, cryoprecipitate 1 year, and granulocytes concentrate 24 hours.</span></span></span></p>",
    "correct_choice_id": 217485,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 32305,
    "choices": [
      {
        "id": 129078,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV 1</span></p>"
      },
      {
        "id": 129079,
        "text": "<p><span style=\"font-size:12.0pt;\">HHV 8</span></p>"
      },
      {
        "id": 129080,
        "text": "<p><span style=\"font-size:12.0pt;\">HBV</span></p>"
      },
      {
        "id": 129081,
        "text": "<p><span style=\"font-size:12.0pt;\">EBV</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Primary effusion lymphoma is caused by which of the following viruses? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q3729449",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619245,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) HHV 8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary effusion lymphoma (PEL) is a rare type of lymphoma that is most commonly associated with human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV). HHV-8 is implicated in several malignancies, including Kaposi sarcoma, Castleman disease, and PEL. PEL typically presents as lymphomatous effusions in body cavities such as the pleural, pericardial, or peritoneal spaces without detectable tumor masses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. HIV 1</strong>: While HIV infection can predispose individuals to various lymphomas, including PEL, it is not the direct cause. HIV-1 is primarily associated with immunosuppression, which increases susceptibility to HHV-8 and other oncogenic viruses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HBV (Hepatitis B virus)</strong>: HBV is associated with hepatocellular carcinoma but not with primary effusion lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EBV (Epstein-Barr virus)</strong>: EBV is associated with several types of lymphomas, including Burkitt lymphoma and Hodgkin lymphoma, but it is not the primary causative agent of PEL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">HHV 8 causes Castleman disease, Kaposi sarcoma and primary effusion lymphoma.</span></p>",
    "correct_choice_id": 129079,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 24749,
    "choices": [
      {
        "id": 98957,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
      },
      {
        "id": 98958,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deletion of gene</span></span></span></p>"
      },
      {
        "id": 98959,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Translocation</span></span></span></p>"
      },
      {
        "id": 98960,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inversion</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A case of complete gonadal dysgenesis was observed in a 46XY individual with female characteristics. The origin of complete gonadal dysgenesis lies in alterations of the SRY gene. What leads to complete gonadal dysgenesis in the SRY gene?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q7278587",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619246,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Deletion of gene </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete gonadal dysgenesis in a 46XY individual is typically associated with alterations in the SRY gene, which is crucial for initiating male sex determination. The SRY gene, located on the Y chromosome, directs the development of the gonads into testes. When this gene is deleted, it results in a failure to initiate testis formation, leading to a phenotypically female individual with a 46XY karyotype. In 10-15% of cases of 46XY gonadal dysgenesis, the SRY gene deletion is the underlying cause. This leads to a failure in developing male characteristics and results in complete gonadal dysgenesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Point mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Point mutations in the SRY gene can also lead to gonadal dysgenesis, but this accounts for only a small percentage of cases. The mutations typically involve changes in the DNA sequence that alter the function of the SRY protein but do not necessarily delete the gene.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Translocation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Translocation refers to the movement of the SRY gene to another chromosome, which can sometimes lead to sex reversal if the SRY gene is present on an X chromosome in a 46XX individual. However, this is not the primary mechanism for complete gonadal dysgenesis in a 46XY individual.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Inversion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Inversions involve a segment of the chromosome being reversed end to end. This type of chromosomal rearrangement is less commonly associated with gonadal dysgenesis and is not a typical cause of the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete gonadal dysgenesis in a 46XY individual is primarily caused by the deletion of the SRY gene, which leads to a failure in the development of male gonads, resulting in female characteristics.</span></span></span></p>",
    "correct_choice_id": 98958,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 9837,
    "choices": [
      {
        "id": 39315,
        "text": "<p><span style=\"font-size:12.0pt;\">It should be started within 4 hours of receiving it from the blood bank.</span></p>"
      },
      {
        "id": 39316,
        "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 4 hours of receiving from the blood bank.</span></p>"
      },
      {
        "id": 39317,
        "text": "<p><span style=\"font-size:12.0pt;\">No such time restraint and can be done anytime.</span></p>"
      },
      {
        "id": 39318,
        "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 6 hours of receiving from the blood bank.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is correct regarding transfusion of the blood received from blood bank? </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q8193938",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619249,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) It should be completed within 4 hours of receiving from the blood bank.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blood received from blood bank should be completely transfused within 4 hours of receiving.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Principles of blood administration:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">All blood products should be given through an appropriate blood administration set containing a filter.</span></li><li><span style=\"font-size:12.0pt;\">A careful aseptic technique should be practiced at all times.</span></li><li><span style=\"font-size:12.0pt;\">Vital signs should be documented before and after transfusion and as clinically required. For the first 15 minutes after the infusion has begun, the patient should be kept under close observation to detect any signs of a serious transfusion reaction. If none is observed, the infusion rate may be increased.</span></li><li><span style=\"font-size:12.0pt;\">One unit of red cells is often given in 1 to 4 hours, depending on the amount to be transfused and on the patient's cardiovascular status. <strong>Infusion of a unit for longer than 4 hours is not recommended, as there is a risk of bacterial proliferation because the opened unit is at room temperature.</strong></span></li><li><span style=\"font-size:12.0pt;\">No other solution and no medication should be added to or infused through the same tubing as a blood product.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ringer's lactate or other solutions containing calcium must never be added to a blood product because the calcium present leads to coagulation</strong>.</span></li><li><span style=\"font-size:12.0pt;\">After the transfusion has been completed, the transfusion tag or record should become part of the patient's chart.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It should be started within 4 hours of receiving it from the blood bank</strong>: This option is incorrect as the emphasis is on completing the transfusion within 4 hours, not just starting it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. No such time restraint and can be done anytime</strong>: This is incorrect, as there is a specific time frame to prevent bacterial proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It should be completed within 6 hours of receiving from the blood bank</strong>: This option is incorrect; the recommended maximum time for completion is 4 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Blood transfusions must be completed within 4 hours of receiving the blood from the blood bank</strong> to minimize the risk of bacterial proliferation and ensure patient safety.</span></p>",
    "correct_choice_id": 39316,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 10374,
    "choices": [
      {
        "id": 41462,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lead poisoning</span></span></span></p>"
      },
      {
        "id": 41463,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron deficiency anemia</span></span></span></p>"
      },
      {
        "id": 41464,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolytic anemia</span></span></span></p>"
      },
      {
        "id": 41465,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholism</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old male patient presented with a history of fatigue and tiredness. On investigation, he was found to have Hb = 9 gm% and MCV =101 FL. Peripheral smear examination showed macrocytic RBC and hyper-segmented neutrophils. Which of the following is the most likely etiology? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2386185",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619199,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Chronic alcoholism </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given findings are suggestive of macrocytic anemia, which can be seen in chronic alcoholics.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral smear showing macrocytic RBCs and hyper-segmented neutrophils are characteristic features of megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/hypersegmented-neutrophil.jpg\" style=\"height:262px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholics also have deficiency of folic acid due to:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate accumulation in the liver </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Excessive urinary loss </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Impaired folate metabolism</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholics frequently have insufficient dietary intake.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lead poisoning:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lead poisoning typically causes microcytic anemia rather than macrocytic anemia. Peripheral smear findings in lead poisoning include basophilic stippling of RBCs, not macrocytic RBCs and hyper-segmented neutrophils.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Iron deficiency anemia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iron deficiency anemia is characterized by microcytic, hypochromic RBCs, which contrasts with the macrocytic RBCs and hyper-segmented neutrophils seen in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hemolytic anemia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hemolytic anemia generally presents with normocytic or slightly macrocytic RBCs, but not to the extent seen in megaloblastic anemia. Additionally, hyper-segmented neutrophils are not a typical feature of hemolytic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Macrocytic anemia with hyper-segmented neutrophils on a peripheral smear is characteristic of megaloblastic anemia, often due to folate deficiency, which is commonly seen in chronic alcoholics due to impaired folate metabolism and poor dietary intake.</span></span></span></p>",
    "correct_choice_id": 41465,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10461,
    "choices": [
      {
        "id": 41810,
        "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interstitial cystitis</span></span></span></p>"
      },
      {
        "id": 41811,
        "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malakoplakia</span></span></span></p>"
      },
      {
        "id": 41812,
        "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polypoid cystitis</span></span></span></p>"
      },
      {
        "id": 41813,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute cystitis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient underwent cystoscopy, which showed multiple yellow-white plaques in the trigone of the bladder. The histopathology image is given below. What is the diagnosis? (NEET PG 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-475.jpg\" style=\"height:288px; width:400px\" /></p>",
    "unique_key": "Q4349706",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619241,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Malakoplakia </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The cystoscopy findings of multiple yellow-white plaques in the bladder trigone and histopathology image showing Michaelis-Gutmann bodies are consistent with malakoplakia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malakoplakia is a rare condition of unknown etiology primarily affecting the urinary bladder. It is likely associated with chronic inflammation and defective phagocytosis by macrophages. It is more commonly observed in immunocompromised patients and transplant recipients.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">On cystoscopy, malakoplakia appears as multiple yellow-white plaques in the bladder trigone. The lesions are soft, flat, and slightly raised, with sizes ranging from 0.5 to 5 cm.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histopathologically, malakoplakia shows massive accumulation of foamy macrophages, multinucleate giant cells, and lymphocytes.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foamy macrophages contain granular cytoplasm that is PAS-positive.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Michaelis-Gutmann bodies, characterized by cytoplasmic laminated concretions of calcium phosphate, are seen within macrophages.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Michaelis-Gutmann bodies represent lysosomes filled with partially digested debris of bacteria, resulting from defective phagocytosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-144703.png\" style=\"height:223px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Interstitial cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interstitial cystitis is a chronic condition causing bladder pain and frequent, urgent urination. It does not present with yellow-white plaques or Michaelis-Gutmann bodies.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Polypoid cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polypoid cystitis presents with polypoid or papillary projections in the bladder, often due to chronic irritation, such as long-term catheter use. It does not show the specific histopathological features of malakoplakia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acute cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute cystitis is an infection of the bladder characterized by symptoms such as dysuria, frequency, and urgency of urination. The cystoscopy findings would typically show an inflamed, red mucosa, not yellow-white plaques.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malakoplakia is characterized by multiple yellow-white plaques in the bladder trigone, as seen on cystoscopy, and histopathological findings of foamy macrophages with PAS-positive cytoplasm and Michaelis-Gutmann bodies. This condition is associated with chronic inflammation and defective phagocytosis, commonly affecting immunocompromised patients.</span></span></span></p>",
    "correct_choice_id": 41811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9847,
    "choices": [
      {
        "id": 39354,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Ochronisis</span></span></span></p>"
      },
      {
        "id": 39355,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Metallosis</span></span></span></p>"
      },
      {
        "id": 39356,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Malignant melanoma</span></span></span></p>"
      },
      {
        "id": 39357,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Rosai Dorfman disease</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman who had undergone total knee replacement surgery comes with complaints of knee pain with the loosening of implants. The following histopathological slide was obtained which showed foreign body giant cells along with the appearance highlighted in the image below. What is your diagnosis? (AIIMS MAY 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/979.jpg\" style=\"height:290px; width:469px\" /></span></span></p>",
    "unique_key": "Q8329567",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619253,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Metallosis</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The given clinical scenario and image with the said foreign body giant cell point towards a diagnosis of metallosis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Metallosis is an uncommon complication following total joint replacements of high wear joints like hip and knees. It occurs when metallic components in medical implants, specifically joint replacements, abrade against one another. The metal from the prosthesis infiltrates the bone and soft tissue surrounding it resulting in pain or squeaking on weight bearing or loosening of implant. Sometimes it may be asymptomatic with imaging findings (<strong><em>cloud sign or bubble sign</em>)</strong>. Aspiration reveals dark fluid consisting of metallic debris.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Ochronosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ochronosis is a metabolic disorder characterized by the deposition of homogentisic acid in connective tissues, leading to pigmentation and arthritis. It is not associated with metallic debris or foreign body giant cells.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Malignant melanoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Malignant melanoma is a type of skin cancer that would present with different histological findings, such as atypical melanocytes. It does not involve foreign body giant cells or metallic debris.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Rosai-Dorfman disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare disorder characterized by massive lymphadenopathy and histiocytosis with distinctive histological features, including the presence of histiocytes that exhibit emperipolesis. It does not involve metallic particles or joint replacements.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metallosis is a rare complication of joint replacement surgeries, characterized by the release of metallic debris from implants, leading to a foreign body reaction with the formation of foreign body giant cells and potential loosening of the implant.</span></span></span></p>",
    "correct_choice_id": 39355,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9779,
    "choices": [
      {
        "id": 39083,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dystrophic with increased serum calcium</span></span></span></p>"
      },
      {
        "id": 39084,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic with increased serum calcium</span></span></span></p>"
      },
      {
        "id": 39085,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dystrophic with normal serum calcium</span></span></span></p>"
      },
      {
        "id": 39086,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastatic with normal serum calcium</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 58-year-old man died 24 hours after the onset of substernal chest pain radiating to the left arm. On autopsy, an atheromatous plaque was seen obstructing the left anterior descending artery. Which type of calcification is most likely to be seen in this condition?</span> </span></span>(AIIMS MAY 2019)</p>",
    "unique_key": "Q2999498",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619220,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Dystrophic with normal serum calcium</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atheromatous plaques show dystrophic calcification in the presence of normal calcium levels in the serum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The deposition of calcium in dead or dying tissues is called dystrophic calcification. Although it occurs in the presence of normal serum calcium, it can be worsened by hypercalcemia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dystrophic calcification is seen in areas of necrosis of any type - </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in dead tissue &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caseous necrosis in tuberculosis is the most common site for dystrophic calcification. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liquefaction necrosis in chronic abscesses may get calcified.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fat necrosis following acute pancreatitis or traumatic fat necrosis in the breast results in deposition of calcium soaps.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gamma-Gandy bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> in chronic venous congestion (CVC. of the spleen is characterized by calcific deposits admixed with hemosiderin on fibrous tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infarcts may sometimes undergo dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombi, especially in the veins, may produce phleboliths.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hematomas in the vicinity of bones may undergo dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dead parasites like in hydatid cyst, Schistosoma eggs, and cysticercosis are some of the examples showing dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in breast cancer detected by mammography.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congenital toxoplasmosis involving the central nervous system visualized by calcification in the infant brain.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in degenerated tissues</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dense old scars may undergo hyaline degeneration and subsequent calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atheromatous in the aorta and coronaries frequently undergo calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M&ouml;nckeberg&rsquo;s sclerosis shows calcification in the tunica media of muscular arteries in elderly people </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stroma of tumors such as uterine fibroids, breast cancer, thyroid adenoma, goitre etc. show calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Some tumors show characteristic spherules of calcification called psammoma bodies or calcospherites such as in meningioma, papillary serous cystadenocarcinoma of the ovary and papillary carcinoma of the thyroid.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cysts which have been present for a long time may show calcification of their walls e.g. epidermal and pilar cysts.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcinosis cutis is a condition of unknown cause in which there are irregular nodular deposits of calcium salts in the skin and subcutaneous tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Senile degenerative changes may be accompanied by dystrophic calcification such as in costal cartilages, tracheal or bronchial cartilages, and pineal gland in the brain etc.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Dystrophic with increased serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Dystrophic calcification typically occurs in the setting of normal serum calcium levels. While hypercalcemia can exacerbate dystrophic calcification, it is not a defining feature.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Metastatic with increased serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Metastatic calcification occurs when calcium salts are deposited in normal tissues as a result of hypercalcemia. This form of calcification is not associated with tissue injury or necrosis and typically affects tissues like the lungs, stomach, kidneys, and blood vessels under conditions of high serum calcium. It does not apply to the situation described, where calcification is occurring in damaged tissue with normal calcium levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Metastatic with normal serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This option is incorrect because metastatic calcification is always associated with hypercalcemia, not normal serum calcium levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113716.png\" style=\"height:289px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Pg no 83</span></strong></span></span></p>",
    "correct_choice_id": 39085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 50373,
    "choices": [
      {
        "id": 201043,
        "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
      },
      {
        "id": 201044,
        "text": "<p><span style=\"font-size:12.0pt;\">Carotid Body Tumor</span></p>"
      },
      {
        "id": 201045,
        "text": "<p><span style=\"font-size:12.0pt;\">Glioblastoma</span></p>"
      },
      {
        "id": 201046,
        "text": "<p><span style=\"font-size:12.0pt;\">Paraganglioma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Zellballen pattern is not typically observed in which of the following tumors? (NEET PG 2016)</span></p>",
    "unique_key": "Q3762767",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619230,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. Glioblastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zellballen pattern refers to a characteristic histological arrangement seen in paraganglionic tumors where neoplastic cells are arranged in nests or clusters separated by highly vascular fibrous septa. This is a hallmark finding in pheochromocytomas and paragangliomas. Pheochromocytomas are described as being \"composed of polygonal to spindle-shaped chromaffin cells and their supporting cells, compartmentalized into small nests by a rich vascular network\" - this describes the Zellballen pattern. Paragangliomas occurring at sites like the carotid body share similar features, as they derive from paraganglionic tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pheochromocytoma</strong> - This is incorrect because pheochromocytomas do exhibit the Zellballen pattern. Pheochromocytomas are characterized by \"polygonal to spindle-shaped chromaffin cells and their supporting cells, compartmentalized into small nests by a rich vascular network,\" which describes the classic Zellballen arrangement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Carotid Body Tumor</strong> - This is incorrect because carotid body tumors are paragangliomas that occur in the carotid body, a paraganglionic structure. These tumors show the same characteristic Zellballen pattern as pheochromocytomas because they derive from similar neural crest-derived tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paraganglioma</strong> - This is incorrect because these tumours can demonstrate a pattern resembling Zellballen.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;Zellballen pattern (nest-like arrangement of cells with rich intervascular stroma) is a characteristic histological feature of paraganglionic tumors like pheochromocytoma and carotid body tumors, but not of glioblastoma, which shows pseudopalisading necrosis and microvascular proliferation.</span></p>",
    "correct_choice_id": 201045,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 54942,
    "choices": [
      {
        "id": 219229,
        "text": "<p><span style=\"font-size:12.0pt;\">CRP</span></p>"
      },
      {
        "id": 219230,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin</span></p>"
      },
      {
        "id": 219231,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
      },
      {
        "id": 219232,
        "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following plasma protein will decrease in acute inflammation? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q5333729",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619208,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of acute inflammation, most plasma proteins, known as acute-phase reactants, typically increase due to the influence of cytokines like interleukin-6 (IL-6) and interleukin-1 (IL-1). These are referred to as positive acute-phase reactants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, there are certain proteins, called <strong>negative acute-phase reactants</strong>, that decrease during acute inflammation. Albumin is one such protein. The decrease in albumin during inflammation is thought to help conserve amino acids for the production of more essential proteins needed during the inflammatory response. Additionally, lower albumin levels help to reduce blood viscosity and facilitate the movement of immune cells to sites of inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CRP:</strong> C-reactive protein (CRP) is a well-known positive acute-phase reactant. Its levels significantly increase during inflammation, making it a common marker for detecting inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hepcidin:</strong> Hepcidin is another positive acute-phase reactant. It increases during inflammation and plays a role in iron metabolism, often contributing to the anemia seen in chronic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ferritin:</strong> Ferritin, an iron-storage protein, also acts as a positive acute-phase reactant. Its levels rise during inflammation, reflecting increased storage of iron in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Negative acute-phase reactants \u2013 Albumin, Transferrin, Transthyretin</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Positive acute-phase reactants - CRP, hepcidin, and ferritin</span></p>",
    "correct_choice_id": 219232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Pathology-3)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>